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Abstract 
 
 
Project 1: A step towards characterising a microRNA regulatory system in the parasitic 
nematode Haemonchus contortus 
 
Haemonchus contortus, a parasitic nematode of small ruminants presents significant 
problems to the international farming industry which are confounded by multi-anthelminthic 
resistance. Better understanding of this parasite and its developmental requirements are a 
priority for the development of novel therapeutic agents. Parasite specific microRNAs (small 
non-coding RNAs which regulate gene expression) are potential future anthelminthic targets. 
However, little is known about microRNAs regulatory systems in parasitic nematodes. Here, 
we aimed to examine whether H. contortus expressed lin-41, a mRNA target for let-7 
microRNA. H. contortus lin-41 (Hc-lin-41) was amplified and sequenced, as was its 3′  
untranslated region (3′ UTR). Six potential let-7 binding sites were identified 
bioinformatically in the 3′ UTR of Hc-lin-41. It can be concluded from this that the regulation 
of lin-41 mRNA by let-7 microRNA is a valid avenue for further research in H. contortus.  
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Project 2: Preliminary results from a web-based questionnaire to explore equine 
demographics and vaccination in Great Britain 
 
Epidemiological investigations into recent outbreaks of equine infectious disease have been 
hampered by lack of readily available demographic information about the susceptible 
population. Endemic diseases such as equine influenza and herpes virus continue to cause 
economic loss and cases of equine tetanus are reported each year despite availability of 
vaccinations against these diseases.  This is the first study to investigate the association 
between equine demographic variables and vaccination practices.   
 
Our objectives were to describe British equine demographics and vaccination coverage and to 
identify factors associated with reduced likelihood of vaccination. 
Data were collected using a web-based questionnaire for horse owners. Answers from 
questionnaire participants between 16
th
 of November 2010 and 10
th
 of March 2011 were 
described and summarised. Univariable analyses of the association between demographic 
factors and vaccination practices were performed. 
 
Of 4187, respondents, 4094 listed valid British post-codes and 3277 (80%) answered all of 
the mandatory questions in the questionnaire. The highest percentage (16.3%) of respondents 
lived in South West England and the majority (73.5%) kept their horses within 2.5 miles of 
where they lived. Horses most commonly lived on their owners‟ own premises (31.6%). Most 
(70.7%) respondents owned and also rode horses. Hacking (leisure riding) was the most 
popular activity with 93.5% of respondents reporting participation. Horses were imported by 
3.5% of respondents and 3.7% travelled internationally. Equine influenza, tetanus and herpes 
virus vaccination was reported by 90.3%, 95.1% and 9.2% of respondents respectively. 
Region, type of premises, type of area, the respondent‟s type of equestrian involvement, 
international travel, importation, distances travelled to equine events and the respondent‟s 
gender and age group were associated with likelihood of vaccination.   
 
This web-based questionnaire was a useful way to obtain information about the British 
equine population. The identification of factors associated with reduced likelihood of 
vaccination can facilitate targeting of vaccination and identification of at risk groups in the 
case of an outbreak of infectious disease.  
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Project 3: Characterisation of G proteins in myelin isolated from the rumpshaker mouse 
model of Pelizaeus-Merzbacher disease 
 
The rumpshaker mutation of the gene Plp1 (Ile
186
Thr) that encodes the major myelin protein 
proteolipid protein (PLP) causes dysmyelination and spastic paraplegia or mild Pelizaeus 
Merzbacher disease in man. The identical mutation occurs spontaneously in mice. The 
pathogenic pathway between the rumpshaker mutation and dysmyelination has not been 
elucidated. Phosphotidylinositol 4,5-bisphosphate (PIP2) has recently been shown to 
influence the stability of the myelin basic protein (MBP) that is critical for competent myelin 
formation. In a preliminary study, PIP2 levels have been found to be reduced in rumpshaker 
mice. Since Gαq is known to initiate phospholipase C mediated hydrolysis of PIP2 this raises 
the possibility that aberrant G-protein activity may be involved . In the first study to measure 
G-proteins in rumpshaker myelin, we found Gαq and Gαo levels to be significantly elevated in 
myelin from C3H rumpshaker mice. These findings implicate G proteins as important 
mediators in a pathway linking mis-folded PLP to MBP dysfunction and may underpin the 
mechanisms causing dysmyelenation in the rumpshaker mouse. 
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General introduction 
 
This thesis describes projects in three different fields; molecular biology, epidemiology and 
cell biochemistry. Whilst centred around three diverse topics, the projects‟ common aim is to 
address an animal or human disease problem through a novel approach. The spectrum of the 
projects is consistent with the aims of the scientific community to address disease challenges 
from the level of the molecule to the level of a whole population.  
 
The first project investigates a micro RNA regulatory system in the parasitic nematode of 
sheep, Haemonchus contortus. Multi-drug resistance in parasites is a major problem for the 
global livestock industry, with H. contortus, a parasite of sheep threatening the industry due 
its resistance to all major anthelminthics. The first project contributes towards using 
microRNA findings in the model organism Caenorhabitis elegans as a possible avenue to 
control H contortus. Little is known about microRNAs in parasitic nematodes and hence our 
aim was to characterise a microRNA regulatory system, the let-7 microRNA and lin-41 
mRNA that is well described in C elegans, in its clade V relative, H contortus.  The 
hypothesis was that the microRNA target, lin-41 and potential let-7 microRNA binding sites 
on the 3′ untranslated region of this mRNA would be present in H contortus.  
 
The second project is a study of British equine demographics and the vaccination practices of 
horse owners and carers. Recent outbreaks of equine infectious anaemia in Europe and equine 
influenza in Australia as well as the threat of African Horse Sickness have highlighted the 
need for more complete demographic information about the equine population to be at hand 
in order to be prepared for future disease outbreaks. Relative to food animals, equine 
identification and demographic knowledge in Britain is incomplete. The second project in 
this thesis is the preliminary analysis of a web-based questionnaire of horse-owners with over 
4000 respondents. The questionnaire aimed to collect demographic information about the 
British equine population relevant to the spread of infectious disease. As well as summarising 
questionnaire responses, objective of the project was to analyse demographic factors 
associated with increased or reduced likelihood of vaccination against equine diseases.  
 
The third project is a cell biochemistry project based on measuring G protein levels in the 
rumpshaker mouse model of Pelizeus Merzbacher Disease (PMD), a debilitating congenital 
15 
 
dysmyelinating disorder of the central nervous system. At present, there is no cure for PMD. 
It is known that mutations in the proteolopid protein gene (PLP-1) cause the disease but it is 
not known how the mutation results in the end phenotype. The rumpshaker mouse contains 
the identical mutation to humans with the mild form of PMD (hereditary spastic paraplegia), 
Recent studies have linked Phosphatidylinositol 4,5-bisphosphate (PIP2) to myelin basic 
protein function, which is essential for normal myelination. G proteins are known to effect 
PIP2 levels. Subsequently, our hypothesis was that G-protein levels would be altered in the 
myelin of rumpshaker mice. This is the first study to investigate G proteins in rumpshaker 
myelin.  
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Chapter 1: A step towards characterising a microRNA 
regulatory system in the parasitic nematode Haemonchus 
contortus 
 
 
1.1 Introduction: 
 
Haemonchus contortus is a parasitic nematode of sheep and goats of global economic 
significance.  In 2005, intestinal parasitic nematodes of sheep (predominantly H. contortus 
and Teladorsagia circumcincta) were estimated to cost the UK economy alone £84M 
(Nieuwhof and Bishop, 2005). It is an aggressive blood feeder in the abomasum, causing 
anaemia, diarrhoea and weight-loss in its host. Together with other trichostrongyloid 
parasites such as T. circumcincta and equine cyathastomes, H. contortus exhibits a worrying 
array of resistance to a spectrum of anthelminthics, including benzimadazoles, 
tetrahydropyramidines/imidithiazoles and macrocytic lactones (Echevarria et al., 1996; 
Waruiru et al., 1998). Triple-resistant parasites have been reported internationally, including 
in Scotland. Native breed resistance (Chaudary et al., 2007; Miller et al., 1998) and narrow 
spectrum novel drugs such as closantel and monepantel offer some hope for the management 
of haemonchosis. However, economic considerations preclude the use of native low 
productivity tropical breeds in many countries. Furthermore, the alacrity with which 
resistance developed to macrocylic lactones which were initially thought to be the “magic 
bullet” of anthelminthic treatment, mean that development of novel therapies and effective 
use of existing drugs is a priority.  
 
MicroRNAs are endogenously produced, small, non coding RNAs that regulate the 
translation of mRNA. They commonly (but not always) bind to the 3′  untranslated region of 
the mRNA that they are regulating and exert a negative effect on the translation of that 
mRNA (Vella and Slack, 2005). The first microRNA, lin-4, was discovered by  Lee et al., 
(1993) in the free living nematode and model organism Caenorhabditis elegans.  The 
discovery of let-7, a second microRNA involved in the post-transcriptional regulation of 
heterochronic genes in  C.elegans by Reinhart et al., (2000) simulated great interest in micro-
RNAs. let-7 microRNA was found to be highly conserved in many species, including humans 
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(Pasquinelli et al., 2000), engendering much research into let-7 and its targets. Whilst the 3′ 
UTRs of five different heterochronic genes have regions that were complementary to let-7, 
only the negative regulation of lin-41 by let-7 during the L3 and later stages appear to impact 
the normal progression of  the life cycle of C.elegans, as shown in Figure 1.1 (Reinhart et al., 
2000). 
 
Figure 1.1: The role of let-7 microRNA in the control of late temporal transitions in the development of 
C.elegans. In the fourth larval stage, the seam cells of let-7 mutant C.elegans fail to fuse normally and 
continue to proliferate, eventually causing vulval bursting. C. elegans lin-41 mutants have the opposite 
phenotype, with premature fusion of the seam cells (Reinhart et al., 2000). 
 
 
Subsequent to the discovery of microRNAs in C. elegans, a myriad of microRNAs and 
microRNA targets have been discovered, with 30% of human genes potentially being 
regulated by microRNAs (Rajewsky 2006). The role of microRNAs in resistance of 
neoplasms to chemotherapeutic agents is well documented (reviewed by Ma et al .(2010) and  
Zheng et al.,( 2010)). Furthermore, recent work on C.elegans, indicates that microRNAs may 
also play a role in drug resistance in nematodes (Simon et al., 2008). Rao et al., (2009) found 
that a single nucleotide polymorphism in the 3′ UTR of a gene encoding ion channels in H. 
contortus to be associated with ivermectin resistance and postulated that this was at a 
microRNA binding site. A recent review proposed the investigation of microRNA regulation 
of both drug targets and drug evasion mechanisms in H. contortus as a logical but novel 
approach to the problem of anthelminthic resistance in parasitic nematodes (Devaney et al., 
2010). 
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Like C. elegans, H. contortus is a Clade V nematode and mechanisms regulating 
development, such as microRNAs and their targets, may be conserved. In order to pursue 
microRNAs or their binding sites as potential drug targets in H. contortus, their presence and 
action in the worm must be validated. Due to much cross-species research, let-7 is the best 
understood microRNA. The regulation of the hetero-chronic gene lin-41 by let-7 has been 
extensively studied in C. elegans. Consequently, this is the ideal microRNA system with 
which to begin investigations into microRNA activity in H. contortus. This study aims to 
contribute to the understanding of microRNAs in H. contortus by yielding information about 
the let-7 target lin-41 mRNA. Specifically, the objectives of the study are to confirm the 
presence of Hc-lin-41, to determine its nucleotide sequence and to determine the nucleotide 
sequence of 3′ UTR of Hc-lin-41 and seek let-7 complementary sites on this 3′ UTR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
19 
 
1.2 Materials and methods: 
 
1.2.1 cDNA production from an adult population of H. contortus 
Total RNA was extracted from a mixed sex population of adult H. contortus harvested from a 
single infected sheep after 28 days of infection (kindly provided by the Moredun research 
institute and Dr Buddhini Samarasinghe) and cDNA was produced from this using a 
commercial protocol (Affinity Script multiple temperature cDNA synthesis kit, Stratagene). 
 
1.2.3 Bioinformatics 
The publically available nucleotide and translated sequences for Ce were obtained from  
Wormbase” (www.wormbase.org). Available known Hc supercontigs were obtained from the 
Sanger institute (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/h_contortus). For 
nucleotide and translated sequence comparison, alignment and primer design, the publically 
available Basic Local Alignment search tool (BLAST) 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) or the bioinformatics programme Vector NTI 
(Invitrogen) were used.  For seeking out potential let-7 microRNA complementary sites, 
RNA Hybrid (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/submission.html) was used. 
Where nucleotide sequence was translated to amino acid sequence, the Prosite proteomics 
programme (http://us.expasy.org/tools/dna.html) was used. Peptide motifs also were 
identified in translated sequences and diagrammatically represented using the Prosite 
programme (http://expasy.org/prosite/). 
 
1.2.3 PCR to amplify the 5′ end of Hc-lin-41, full-length Hc-lin-41and Hc-lin-41 3′ UTR 
Oligonucleotide primers were synthesized commercially by Eurofins MWG Operon. 
Templates, primers and cycle times used for each PCR are described in Table 1.1. 
Amplification of Hc-sod-1 (Liddell and Knox 1995) and Hc-actin-1 (primer sequences from 
Dr. Buddhini Samarasinghe) was used as PCR controls. Products were visualised on 1% 
agarose gels containing 0.003% ethidium bromide (10mg/ml).  
To amplify the full length Hc-lin-41, a product containing a high fidelity polymerase (PFU 
turbo, Stratagene) was used. The high-fidelity polymerase was added to reduce the chance of 
error in the amplification of a long DNA fragment.  
After the 3′ end of Hc-lin-41 was identified, the 3′ RACE technique was used to amplify the 
3′ UTR of this gene. Two gene specific forward nested primers from the 3′ end of Hc-lin-41 
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and the Abridged Universal Amplification primer (AUAP) were used in the Invitrogen 
protocol for 3′  RACE (Table 1.1). 
Table 1.1: PCR conditions for the amplification of the 5′ end of Hc-lin-41, full-length and Hc-lin-41 3′ 
untranslated region. 
cDNA amplified Template Primers Pol  Cycle stage Temp Time Cycles 
5 ′  portion of Hc-
lin-41 Hc-cDNA 
SL-1, 
Hc-lin-
41 -R1 Taq  Denaturation 94°C 3 m 1 
                
        Denaturation 94°C 30s   
        Annealing 55°C 30s 30 
        Extension 72°C 3m   
                
        
Extra 
extension 72°C 5m 1 
Full length Hc-lin-
41 Hc-cDNA 
Hc-lin-
41 
Forw, 
Rev 
PFU 
turbo Denaturation 94°C 3 m 1 
                
        Denaturation 94°C 1m   
        Annealing 55°C 1m30s 30 
        Extension 72°C 8m   
                
        
Extra 
extension 72°C 5m 1 
3′  RACE primary 
PCR  Hc-lin-41 3′ 
UTR  Hc-cDNA 
Hc-lin-
41-F3, 
AUAP Taq Denaturation 94°C 3 m 1 
3′  RACE, nested 
PCR for Hc-lin-41 3′ 
UTR 
PCR product 
of Hc-lin-41-
F3 and AUAP 
Hc-lin-
41-F4, 
AUAP Taq Denaturation 94°C 30s   
        Annealing 55°C 30s 30 
        Extension 72°C 2m   
                
        
Extra 
extension 72°C 5m 1 
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1.2.4 Cloning of the 5 ′ portion of Hc-lin-41, full length Hc-lin-41 and Hc-lin-41 3′ UTR 
PCR products for cloning and sequencing were extracted from the agarose gel and purified 
using QIA quick gel extraction kit 
(http://www.qiagen.com/products/dnacleanup/gelpcrsicleanupsystems/qiaquickgelextractionk
it.aspx).  Where products had been amplified with Taq polymerase, the purified DNA was 
ligated to pSC-A-amp/kan cloning vectors containing the Lac Z  (beta-galactoside) gene 
(Strataclone PCR cloning kit (http://www.genomics.agilent.com/files/Manual/240205.pdf). A 
competent cell line (from Strataclone PCR cloning kit) was transformed with these vectors 
and was cultured on Luria-Bertani Broth (LB) agar containing ampicillin and a marker of 
beta-galactoside activity, X-gal.  After overnight incubation at 37°C, colonies that had been 
transformed by successfully ligated vectors (as evidenced by lack of beta-galactoside activity 
shown by blue-white selection) were sampled.  DNA was extracted from the samples using 
the QIAprep Spin Miniprep kit 
(http://www.qiagen.com/products/plasmid/qiaprepminiprepsystem/qiaprepspinminiprepkit.as
px).  Colony PCR was performed with the primers used in the original PCR. Colonies 
corresponding with amplification of DNA fragments of the same size as the original PCR 
products were inoculated overnight in large volume tubes containing LB. Plasmid DNA from 
these colonies was then purified using the QIAprep Spin Miniprep kit. The DNA yielded 
from plasmid purification was subjected to spectrophotometry at a wavelength of 260nm to 
determine its concentration. The concentration of samples selected for commercial 
sequencing was adjusted to 100ng/microlitre.  
 
Where Hc-lin-41 was amplified with PFU Turbo polymerase, which does not add poly-A tails 
to PCR products, gel extracted DNA was adenylated following the protocol from Strataclone 
PCR cloning kit before being ligated to pSCA-A vectors and subjected to the cloning 
protocol described above. Due to the extended PCR that was required for amplification of the 
potential Hc-lin-41 fragment (Table 1.1), the presence of Hc-lin-41 cDNA  in the plasmid 
DNA was tested with a PCR using primers (Hc-lin-41-F2, R1, table 1.2) for a 300bp length 
from a previously sequenced portion of the potential Hc-lin-14 rather than primers for the full 
length of the gene. 
 
Prior to commercial sequencing, in order to confirm the presence of the Hc-lin-41insert, 
plasmid DNA was subjected to a restriction digest using EcoRI which is a restriction site on 
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both TOPO and psc-A vectors. The products of the restriction digest were visualised on 1% 
agarose gels containing 0.003% ethidium bromide.  
 
Dideoxynucleotide sequencing was performed commercially by Eurofins MWG Operon.  
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1.3 Results: 
1.3.1 Alignment of C. elegans LIN-41 with available translated H. contortus supercontigs 
The translated Hc supercontig 0048734 contained three areas which had a high degree of 
sequence identity to amino acid sequences near the C terminal of C. elegans LIN-41. These 
three high scoring pair (HSP) areas were 122, 174 and 1861 nucleotides in length with 48%, 
73% and 85% identical amino acid matching (respectively) and 67%, 90% and 91% 91% 
similar amino acid matching. Primers were designed from these areas (Figures 1.2, 1.3 and 
Table 1.2). As the chosen HSP areas aligned near the C terminal of Ce LIN-41, the primers 
designed from them were deemed likely to be complementary to the 3′ end of the 
hypothetical Hc-lin-41 cDNA. No alignment between translated Hc supercontigs and the N 
terminal of Ce LIN-41 was achieved (Figure 1.2).  
 
Figure 1.2: Alignment of Caenorhabditis elegans LIN-41(Ce LIN 41) and potential translated 
Haemonchus contortus lin-41 mRNA. The high scoring pair areas of alignment between Haemonchus 
contortus supercontig 004874 and Ce LIN-41 were located near the C terminal of Ce LIN-41. 
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Figure 1.3: Primer locations on Haemonchus contortus supercontig 0048734.  Primers were designed 
from the high scoring pair areas that aligned near the C terminal of Ce LIN 41. The location of the stop 
codon on the supercontig is also highlighted. This is drawn to approximate scale using the “Vector NTI” 
alignment programme. 
 
 
 
 
Table 1. 2: Nucleotide sequences of primers designed from Haemonchus contortus supercontig 0048734. 
Except for Hc-lin-41 –Rev all primers shown in the table were designed from the high scoring pair (HSP) 
areas on the super-contig that aligned with Caenorhabditis elegans LIN-41. Hc-lin-41-Rev was designed 
from an exon in Haemonchus contortus supercontig 0048734 beside the stop codon nearest the HSP areas 
that aligned with Caenorhabditis elegans LIN-41). 
 
Primer Name Primer Sequence (5′ →3′) Corresponding 
nucleotides 
on Ce lin 41 
(total length 
3444bp) 
Hc-lin-41 F2 CAATATTGTGGTAGCCGATAAGG 2703-2726 
Hc-lin-41 F1 GTGGTAGCCGATAAGGACAACC 2713-2736 
Hc-lin-41 R2 CCGTTCTCATCGAACACTTGG 2771-2750 
Hc-lin-41 F3 CAGGTATTCAATGAAAATGGCC 2892-2914 
Hc-lin-41 R1 GGAGTTGACCATCAGATAGG 3007-2987 
Hc-lin-41 F4 CGTTTGGCCGTGCTGTCCTCTCG 3030-3053 
Hc-lin-41 Rev TTAGAAAACGCGGATGCAATTGTTGCCG Exon near stop 
codon nearest 
to HSP areas 
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1.3.2 Amplification of the 5’ end of Hc-lin-41 
A primer was designed based on the trans-spliced sequence “Spliced leader 1” (SL-1, 
GGTTTAATTACCCAAGTTTGAG) that is known to be present on 70% of the 5‟ends of all 
C. elegans  mRNA (Blumenthal and Steward, 1997). A DNA fragment of  2.5kbp  in size 
was amplified in  PCR using adult Hc cDNA and the primers SL-1 and Hc-lin41-R1 (Figure 
1.4). As a control, PCRs were performed under the same conditions using SL-1 alone and R1 
alone. These control PCRs did not amplify cDNA fragments. This 2.5kb fragment was 
reamplified, purified, cloned, sequenced and analysed bioinformatically. Sequences of 630bp 
in length were identified for DNA adjacent to the SL-1 and Hc-lin41-R1 sequences.  Upon 
BLAST with known Hc supercontigs, the identified sequences aligned perfectly with portions 
of Hc supercontig 0048110.  
As the SL-1 primer was a non specific primer, a gene specific forward primer was needed 
from the sequenced Hc-lin-41. Amplification of  5‟ end  of Hc-lin-41 with this new primer 
replacing the SL-1 primer increased confidence that the amplified fragments were the 5‟ end  
of Hc-lin-41 rather than erroneously amplified fragments. As the sequenced area adjacent to 
the SL-1 sequence was potentially the 5‟ end of Hc-lin-41, the new gene specific primer, Hc-
lin-41-Forw (ATGCAGCGAGTGGATTCCCGAAGCG), was designed from here.  
 
Figure 1.4: Amplification of the 5′  PCR products. A PCR using adult Haemonchus contortus cDNA. The 
primers SL-1 and Hc-lin41-R1 and Taq polymerase amplified DNA fragments of  2.5kbp  in size (shown 
here on an ethidium-agarose gel). 
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1.3.3 Amplification of the full length of Hc-lin-41 
A PCR using adult Hc cDNA, Hc-lin-41-Forw and Hc-lin-41 Rev primers and “PFU turbo” 
high fidelity polymerase amplified DNA fragments of just under 3kbp in size (Figure 1.5). 
This was reamplified, purified, cloned, sequenced and analysed bioinformatically. This 
yielded nucleotide sequences of 629 and 700 bp in size from the 5‟ and 3′ ends of the 
potential Hc-lin-41 respectively. These sequences were aligned with the sequences from the 
SL-1 and R-1 product and showed perfect homology.  
Primers, Hc-lin-41-R3 and Hc-lin-41-F5, for internal sequencing of the full length Hc-lin-41 
cDNA fragment were designed based on the end of the sequenced portions of the potential 
Hc-lin-41. These were used with the purified Hc-lin-41 plasmid DNA to sequence the 
remainder of Hc-lin-41 (Table 1.3).  
 
Figure 1.5: Amplification of full length Hc-lin-41. A PCR using Haemonchus contortus adult cDNA. the 
primers Hc-lin-41-Forw and Rev and PFU turbo polymerase amplified DNA fragments of  just under 
3kbp in size (shown here on an ethidium-agarose gel). 
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Table 1.3 : Hc-lin-41-R3 and Hc-lin-41-F5 primers. These were designed based on the ends of the 
sequenced portions of the potential Hc-lin-41 for internal sequencing of this DNA fragment. 
 
Primer 
name 
Primer sequence Origin 
HC lin-41-
R3  
CAC GCC TGG GTC GCT TTC GCT TCG 
TC 
From sequenced Hc-lin-41-R1 
portion 
HC lin-41-
F5  
GTCTGAGCGATCTGTCCGGTCATTTG From sequenced SL-1 portion 
 
1.3.4 Bioinformatic analysis of full length Hc-lin-41 
All sequenced portions of Hc-lin-41 were then aligned with to identify a full length gene of 
2871 bp in size.  This was translated to Hc LIN-41 amino acid sequence (Figure 1.6) and 
compared to Ce LIN-41. BLAST indicated 41% identical matches and 55% similar matches. 
There was a far greater density of high scoring pairs near the C terminals of Hc LIN-41 and 
Ce LIN 41. i.e. when the half of  Hc LIN-41 adjacent to its C terminal was aligned with Ce 
LIN 41, there were 61% and 75% identical and similar matches respectively. Protein motifs 
were identified in Hc-LIN-41 sequence and compared to human and Ce-LIN-41. These three 
species had a Zinc-finger B-box motif near the centre of their open reading frames. They also 
expressed filamin repeats and 6 repeat NHL motifs near their C termini, whilst a zinc finger 
ring motif was expressed uniquely at the N terminus of human LIN-41 (Figure 1.7).  
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Figure 1.6: Alignment of H. contortus LIN-41 and C. elegans LIN-41. High scoring pair areas are 
concentrated towards the C terminals of both translated sequences. Overall identical amino acid matches 
were 41% and similar matches were 55%. However, when the half of  Hc LIN-41 adjacent to its C 
terminal was aligned with Ce LIN 41, there were 61% and 75% identical and similar matches 
respectively. 
 
Cel-LIN-41A (AF195610)     (1) MATIVPCSLEKEEGAPSGPRRLQTEIDVDANDSGNELSMGGSSSEGDSMS 
            Hco-LIN-41     (1) --------------------MQRVDSRSEEAEGAGQKTGGGATTTGPFTT 
Cel-LIN-41A (AF195610)    (51) HHRGEHSPNHHHQDNHLGSGPPPPQFTGSLFDTPPSMIQSPQQQPQFQFN 
            Hco-LIN-41    (31) DGQDTFSP---------SNG-----YHGSLFETPQSLLSSPQ-------Y 
Cel-LIN-41A (AF195610)   (101) TGFGLGLPQDSFRCSVCSKSSTIGVLPFVCAHKTCQSCYQMTPSSYDRRA 
            Hco-LIN-41    (60) DMFSSPFRSSQQRCSLCQKDIQGQHRQFPCSHKICGHCCSLADS----RK 
Cel-LIN-41A (AF195610)   (151) CKLCGAVSTATANFTSQMYLSPTLPSPPRGALMSDCSTPTMNNHINSSTP 
            Hco-LIN-41   (106) CLIC-YASAGTSPFPPYMFLSPPH-------------TDHSNELLDSSLS 
Cel-LIN-41A (AF195610)   (201) LHQPRAFSFSLSGMPGSPSPVMGARMPSSAGGLMMRPIGFPDSDSSLTSW 
            Hco-LIN-41   (142) LHNQSIASYQNG----------------LTDSLHSVNLGLSDLSGHLESF 
Cel-LIN-41A (AF195610)   (251) SPLQQPSQLSINNLSSIGGHQQQSPMLMQNVFDSLAVNDDTPVFSPLSPT 
            Hco-LIN-41   (176) NLWDNRTKIPTTPRSSASQG------IVLPEPPARQEEDHPPVFSPNS-- 
Cel-LIN-41A (AF195610)   (301) NTSMHMPPSLMASPDVPKHSATIAPPRNSMCSTPRLQLATPMSSQSQQTF 
            Hco-LIN-41   (218) --------QLVTTPPVTSPLSMIP-------------------------- 
Cel-LIN-41A (AF195610)   (351) PIPSPLGSQPQQQQPMGPIQCQGCESKISFAYCMQCQEALCIHCVQAHQR 
            Hco-LIN-41   (234) ------SSNVNTQRSMLPSCATCGENARAEAFCANCRELLCGLCVVAHQR 
Cel-LIN-41A (AF195610)   (401) VRATKQHAFVELQQLMATLMSRAVQPQQAQQYTQNVGGSVRQALGSVGSG 
            Hco-LIN-41   (278) VRVTRDHVVISLQQLLNHMTANAFG------------------------- 
Cel-LIN-41A (AF195610)   (451) DGHVSGVENDSIGSGESSPRSSSVCGTHDSVIIGICENCPHSVLLCAICV 
            Hco-LIN-41   (303) ----TGEDGALGGSSDSSPRPSSVCSTHDAKVFCSCETCGR-LSLCAHCI 
Cel-LIN-41A (AF195610)   (501) AQHPGKHRVQPLGDIRVAVGEVVNESQLLQWQCEKTGDTIKQIIDGIVTN 
            Hco-LIN-41   (348) SRHS-SHHIVPLGDVRACVVAMLAESRRNERSIEEAVESVRTMSERVDAS 
Cel-LIN-41A (AF195610)   (551) ATTAENEIRAAFDTHVNALEERRKELLKRVETVKNLKLSVLISQAESLQS 
            Hco-LIN-41   (397) VQAAASELRSLIHLHMSALEERKRELLQRVDTIRQSKTKNLKAQAENLNA 
Cel-LIN-41A (AF195610)   (601) KQIDLQQAIQTATKLMDSSDCDEMVLRQVFEKLASCQMGNEGTEPNNNIL 
            Hco-LIN-41   (447) AKAKFAQTIKSVEAVTAEDDNSQLAS--AFQELIQLYATPIHLIP----- 
Cel-LIN-41A (AF195610)   (651) NVLMLACQVNEDDRLKFTAPQDGILLNKARQFGNIESGPCAKNSSIVGDS 
            Hco-LIN-41   (490) ---------HENDAVKFSVPDN-QLLSQIRALGELESGPCARQCHLVGEG 
Cel-LIN-41A (AF195610)   (701) FKKAIRERQTVIYVQLRDACGDLLSSSIAATQPTSQALLPHQEPHSHLEQ 
            Hco-LIN-41   (530) YKRPIRERQCIVYVQLRDACGEVVPTDRADGG------------------ 
Cel-LIN-41A (AF195610)   (751) AMPTSDVQAFVISPDGSTVEVTMTPRE--NGIVALSYYPSIEGSYTLNIL 
            Hco-LIN-41   (562) ---VRDITATVIAPDGRNLEIHIGRSESDPGVIGIAYYPILDGQHQLDIR 
Cel-LIN-41A (AF195610)   (799) VKGTPISGCPTTMDIRRGRNYDEIAAKGPILTFGKEGSGDGELCRPWGIC 
            Hco-LIN-41   (609) IRGVSISGCPAVVDVRHGRNYAEIAAQGELFSFGKEGSADGELCRPWGIC 
Cel-LIN-41A (AF195610)   (849) VDQRGRVIVADRSNNRVQIFDKDGNFISKFGTSGNRPGQFDRPAGITTNS 
            Hco-LIN-41   (659) VDLRGRVLVADRSNNRIQIFDRDGGFLAKFGCGGTRSGQFDRPAGVTVNT 
Cel-LIN-41A (AF195610)   (899) LNNIVVADKDNHRVQVFDENGMFLLKFGDRGRAVGYFNYPWGVATNSHNA 
            Hco-LIN-41   (709) RNNIVVADKDNHRIQVFDENGNFLLKFGERGRPIGMFNYPWGVATNSQNH 
Cel-LIN-41A (AF195610)   (949) IAVSDTRNHRVQIFTPQGQFVRKCGFDSAYFFKNLDSPRGLCYLPDGQLL 
            Hco-LIN-41   (759) IAVSDTRNHRVQVFNENGQFIRKCGFDTAFFYKHLDSPRGVCYLSDGQLL 
Cel-LIN-41A (AF195610)   (999) ITDFNNHRLAVLSPRNMSEMKVYGSEGDGDGMFVRPQGVVIDPEGHILVC 
            Hco-LIN-41   (809) ITDFNNHRLAVLSSRDTPEMKVYGTEGSVEGMFCRPQGVKVDPEGHILIC 
Cel-LIN-41A (AF195610)  (1049) DSRNNRVQVFASDDMRFIGSFGLGPVPNSGFQMPQELPAPYSSLG----G 
            Hco-LIN-41   (859) DSRNNRVQVFSGDDMRCIAVFGQSSS-SGGFEMPAELPAPFRSVGPTPFH 
Cel-LIN-41A (AF195610)  (1095) PFGAPAFSSAPTPLTPSPRQLLDRPTDLAVGPDGRIYVVDFGNNCIRVF 
            Hco-LIN-41   (908) ASTTPASGVALETPTGGPRPLLDRPTDVAIAPDGRIYVVDFGNNCIRVF 
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Figure 1.7: A comparison of the peptide motifs of human, C. elegans and H.contortus LIN-41. These 
motifs were searched for and graphically represented in the Prosite programme. Human and C. elegans 
LIN-41 sequences were obtained from the NCBI website.  All three species share filamin and six NHL 
repeats near their C terminals as well as a Zinc finger B-Box motif in the centre of their LIN-41 
sequences.  A zinc finger ring motif was recognised at the N terminal of human LIN-41 alone.  
 
 
1.3.5 Identification of the 3′ UTR of Hc-lin-41 using 3’ RACE and identification of 
potential let-7 binding sites 
Using AUAP and gene specific primersHc-lin-41 F3, 3′ RACE amplified a fragment of 
1.6kbp size (Figure 1.8). This was cloned, sequenced and analysed bioinformatically to 
identify nucleotide sequences of 645 and 627 bp in length adjacent to the F4 and AUAP 
primer sequences respectively. These sequences were aligned with Hc supercontig 0048734 
and found to have excellent sequence identity with either end of a 1659bp portion of the 
supercontig (Figure 1.9 and appendix).  Given that the amplified fragment was 1.6kbp in size, 
and its high degree of sequence identity with the sequenced portions of the Hc-lin-41 3′ UTR, 
this portion of the supercontig was accepted to be the 3′ UTR of Hc-lin41.   Hc-let-7 
microRNA binding sites were sought this portion of the supercontig using the “RNA Hybrid” 
programme. Seven possible binding sites for let-7 were found. Table 1.4 lists these sites and 
shows the imperfect binding which is a feature of microRNA target binding. The 
conformation imposed by this imperfect base pairing between the microRNA and its target is 
represented in Figure 1.10. One of the binding sites at 303 on the supercontig portion was 
before the stop-codon, meaning it was on the Hc-lin-41gene rather than the 3′ UTR. 
 
30 
 
 
Figure 1. 8: Amplification of the 3′ UTR of Hc-lin-41. Using the nested primers Hc-lin-41-F3, -F4 and the 
abridged universal amplification primer (AUAP), a 3′  RACE amplified fragments of 1.6kbp size. 
 
 
Figure 1.9: Alignment of the nucleotide sequences from DNA fragments amplified with 3′ RACE with 
Haemonchus contortus supercontig 0048734. This diagram was created using the “Vector NTI” 
alignment programme and is approximately to scale. The circles represent potential let-7 microRNA 
binding sites identified on the portion of Hc supercontig 0048734 which aligned with the sequences. The 
triangle represents the stop codon and the beginning of the 3These were drawn onto the diagram using a 
graphic programme (Gimp). The red dot represents the stop codon for the Hc-lin-41 gene.  
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Table 1.4: Locations of let-7 complementary sites on the portion of Hc supercontig 0048734 which aligned 
with the sequenced portions of the 3′ UTR of Hc-lin-41. (Hc = Haemonchus contortus, mfe= minimum 
folding energy). The “seed” refers to the portion near the 5′ end of the microRNA that binds to the 3′ end 
of the target sequence with perfect complementarity. Imperfect base pair matching is a feature of other 
portions of the microRNA target interaction. The likelihood of a true interaction is based on the mfe and 
the length of the area perfect complementarity. 
 
Position on 
1658bp Hc 
supercontig 
portion 
let-7 - Hc-lin-41 3′ UTR interaction 
Mfe 
 
(kcal/mol) 
Seed 
length 
 
(bp) 
Likelihood 
of true 
interaction 
881 
 
-21.1 7 Strong 
952 
 
 
-27.5 8 Strong 
1291 
 
 
-23.1 7 Strong 
 
303 
 
 
-21.4 6 
Not on 3′  
UTR 
464 
 
-20.8 6 Medium 
974 
 
-21.5 6 Medium 
1211 
 
 
-22.5 6 Medium 
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Figure 1.10: A representation of let-7 (microRNA) – Hc-lin-41 (target) interaction at site 952 on the 3′ 
UTR of Hc-lin-4. This was created on the RNA Hybrid programme. 
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1.4  Discussion 
 
We can conclude from our findings that Hc expresses the gene lin-41 and that the 3′ UTR of 
this gene contains potential let-7 microRNA binding sites.  
 
1.4.1 Use of the SL-1 primer 
The use of the trans-spliced SL-1 sequence to amplify the 5‟ end of Hc-lin-41 was a useful 
technique and saved reverting to 5‟ RACE or other methods to amplify the unknown 
sequence. The SL-1 sequence was initially discovered by Murphy et al., (1986) in the mRNA 
of Trypansoma brucei and shortly afterwards by Krause and Hirsh (1987) in C.elegans. This 
sequence is now recognised to reside at the 5‟ end of 70% of all C. elegans mRNA 
(Blumenthal and Steward 1997). SL-1 is also reported to be trans-spliced to the 5‟ end of  H. 
contortus mRNA as well as other parasitic nematodes  (Bektesh et al., 1988) and has been 
used to great advantage in studies where sequencing of Hc mRNA or cDNA was required 
(Rowe et al., 2008).  However, SL-1 is not a gene specific primer. For this reason, once the 
SL-1 technique yielded a potential sequence for the 5‟ end of Hc-lin-41, it was necessary to 
repeat the sequencing using a primer designed from the newly sequenced 5‟ end. The 
amplification of t full-length Hc-lin-41 which, upon translation, had good sequence identity 
with Ce LIN-41 illustrates that this methodology utilising the SL-1 primer was effective in 
amplifying the gene.  
 
1.4.2 H. contortus  LIN-41 sequence identity with other species 
The high degree of sequence identity  between the C terminal ends compared with the N 
terminal ends of Hc-LIN-41 and Ce-LIN-41 is similar to the case in vertebrates (Schulman et 
al., 2005) and Brugia malayi (Ghedin et al., 2007, Dr Alan Winter, unpublished data).  The 
excellent conservation of peptide motifs in H. contortus, C. elegans and human LIN-41 
(Figure1.7) at the C terminal end with an absence of shared motifs at the N terminal end is 
consistent with the divergence of amino-acid sequences at N termini. It explains why initial 
alignment comparing Ce LIN-41 and known translated H. contortus supercontigs did not 
identify any areas with high identity near the N terminus. This absence of conserved motifs 
near the N terminus of LIN-41 across species suggests reduced evolutionary pressure for 
conservation at this site.  
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1.4.4 Let-7 complementary sites in the 3′ UTR of Hc- lin-41 
The presence of six let-7 complementary sites on the 3′ UTR of Hc-lin41 is a positive start 
for investigation into let-7 target interaction in Hc. However, it should be borne in mind when 
considering this result that potential let-7 binding sites identified bioinformatically are not 
evidence of functional let-7 – target interaction.  For example, whilst the 3′ UTRs of five 
different heterochronic genes have regions that were complementary to let-7, only the 
negative regulation of lin-41 by let-7 during the L3 and later stages appear to impact the 
normal progression of the life cycle of C.elegans (Reinhart et al., 2000). There have been 
similar findings with other microRNAs that bind specific targets with great effect but to a 
broad range of further targets with little biological effect. It is believed that these targets are 
acting as microRNA “sponges,” lessening the effect of the microRNAs on their “action” 
targets (Kaufman and Miska, 2010).  
 
Bioinformatic techniques have been shown to identify thousands of complementary sites for 
some microRNAs (Miranda et al., 2006). Furthermore, in C. elegans alone there are 175 
recognised microRNAs (www.mirbase.org). Of these microRNAs, only eight families have 
validated target interactions (Kaufman and Miska 2010).  A recent review highlighted the 
necessity of in-vivo verification of microRNA functions and pathways through genetic 
knockout and study of resultant phenotypes in addition to bioinformatic techniques (Resnick 
et al., 2010).  
 
1.4.4 Future investigation of let-7 – lin-41 interaction in H. contortus and use of C. elegans 
as a transgenic model system 
The above observations from literature regarding the plethora of remaining elucidations to be 
made about microRNA target interactions highlight the rationale of basing initial studies in H 
contortus on the best understood microRNA regulatory system, let-7 and lin 41, in C. 
elegans.  This maximises the knowledge base from which to initiate investigations into a new 
species. 
 
Due to the necessity of a host to complete its life-cycle, sexual reproduction and limited 
response to RNA interference, there are no reliable methods to knock down or over express 
genes directly in H. contortus (Knox et al., 2007; Samarasinghe et al., 2011). However,  C. 
elegans has been successfully transformed to express genes from H. contortus (Britton et al., 
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1999). Furthermore, Ce- let-7 and Hc-let-7 are identical (Pasquinelli et al., 2000). It may be 
possible therefore, to perform a transformation of C. elegans with Hc-lin-41-3′ UTR and a 
green fluorescent protein gene. Changes in green fluorescent protein could highlight the 
interaction between let-7 and Hc-lin-41-3′ UTR during the different life stages and verify if 
Hc-lin-41-3′ UTR functions in a similar manner to Ce-lin-41-3′ UTR. If the interaction 
between let-7 and lin-41 in H. contortus was defined by green floursecent protein expression 
in transgenic C. elegans, it could then be used as a model with which to test methods for 
parasitic microRNA disruption (e.g. using oligonucleotides to bind to the microRNAs and 
inhibit their function as described by Kundu and Slack (2010)). Validating such approaches 
in a trans-genic model would greatly facilitate and expedite selection of the most viable 
microRNA disruption approach for testing in H. contortus itself, making most efficient use of 
resources and minimising the use of experimental sheep. 
 
Quantitation of lin41, let-7 and LIN-41 at the different stages of the life cycle of H. contortus 
would also provide valuable information about the relationship between this microRNA and 
its target in H. contortus and the impact on translation of the target mRNA.  
 
In conclusion, our findings confirm that lin-41 is present in H. contortus and that the 3′ UTR 
of this gene has potential let-7 binding sites. Subsequently, investigation into the interaction 
between let-7 microRNA and lin-41 mRNA in H.contortus is a valid avenue for further 
research.  
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Chapter 2: Preliminary results from a web-based 
questionnaire to explore equine demographics and 
vaccination in Great Britain 
 
2.1 Introduction 
Demographic knowledge of the population at risk greatly facilitates outbreak investigation 
and epidemiological investigation of any kind. Parameters such as disease prevalence, 
incidence, measure of the transmission of an infectious agent, by definition, incorporate the 
population at risk (Trusfield, 1997). Whilst dealing with farm animal disease outbreaks of 
foot and mouth disease (FMD) and bovine spongiform encephalopathy in Britain, the 
industry and authorities had the great advantage of detailed demographic and movement 
information about the populations of food animals at risk. This facilitated rapid investigations 
into the FMD epidemic (Ferguson et al., 2001) and Bluetongue emergence in northern 
Europe in 2006 and in England in 2007 (Anon, 2007b).  
 
In the case of equine disease, such investigations would be challenging as our knowledge of 
the equine population, its whereabouts and movements is incomplete (Robin et al., 2011). 
This was highlighted in a commentary on the Equine Infectious Anaemia (EIA) outbreak in 
Ireland, where the introduction of a standardised approach to horse identification and 
mandatory registration of all equine premises was called for (Branagan et al., 2008). Similar 
advice was issued in a review of the EIA outbreaks in Britain in 2010 (Anon, 2011).   A 
paucity of knowledge of the equine populations at risk was cited as a factor which increased 
the difficulty associated with outbreak investigation of equine influenza (EIV) in Australia 
(Cowled et al., 2009). Similarly, if a large scale outbreak of equine influenza or herpes virus 
was to occur in Britain, it would be very difficult estimate the location and vaccination 
coverage of the non-thoroughbred population at risk.   
 
Efforts have been made to address the issue of equine identification and movement tracing by 
making it a legal requirement for every horse, except a few covered by derogations, to have a 
traceable passport (Anon 2008).  However, it is suggested that 25% of horses in the UK do 
not have a passport (Alison et al. 2009) and that some passports may be duplicated or 
obsolete (Robin et al., 2011). 
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Increased movements of humans, horses and equine products are believed to be the single 
most important factor in the emergence of trans-boundary equine diseases (Herholz et al., 
2008; Leadon and Herholz, 2009; MacLachlan and Guthrie, 2010). This is a particularly 
relevant observation with the planned arrival of elite athletic horses from multiple 
international locations for the 2012 Olympic Games in London. Furthermore, assessment 
records of the European Union‟s Trade Control and Expert System (TRACES) indicate that 
there has been an increase, especially since 2005, in the extent of global horse movements 
(Herholz et al., 2008). 
 
Despite the availability of vaccines, outbreaks of equine influenza continue to cause 
economic loss in endemic countries (Elton and Bryant, 2011; Gildea et al., 2011) as well as 
devastating outbreaks naïve populations such as that in Australia in 2007 (Callinan, 2008). 
Influenza vaccination has been mandatory in competitions affiliated to the Federation 
Equestre Internationale and British Horse-racing since 1981. However, concerns were cited 
in a recent review that the majority of non-competition horses in the UK were not vaccinated 
against influenza (Elton and Bryant, 2011). The results of two recent postal questionnaires 
reported influenza vaccination by 59% of 1431 horse owners (Hotchkiss et al., 2007) and 
unspecified vaccination by 84% of 1111 of fostered donkey owners (Cox et al., 2010). A 
recent survey of indicated that 66.3% of 918 geriatric horses were vaccinated against 
influenza. Inadequate vaccination was cited as an important potential risk factor in an 
epidemiological investigation of 28 influenza outbreaks in Ireland (Gildea et al., 2011). With 
the current situation of epidemics of genetically divergent equine influenza and the ability of 
influenza viruses to cross species, there is great interest in the susceptibility of the British 
equine population to infection (Elton and Bryant, 2011). 
 
Equine herpes viruses (EHV) 1 and 4 can cause respiratory disease and EHV-1 is also 
associated with abortion and neurological disease. There has been an increase in incidence of 
EHV-1 myeloencephalopathy in the past decade with devastating outbreaks at race tracks, 
horse shows and veterinary hospitals internationally (Perkins et al., 2009). It is considered a 
potentially emerging infectious disease in the United States (Anon, 2007a) and there are calls 
to increase population resistance to herpes virus through widespread vaccination.  
 
In the surveys of Hotchkiss et al. (2007) and Ireland et al. (2011), more horses were 
vaccinated against tetanus than for flu (82.8% and 67% respectively). However, despite the 
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strong protective effect of vaccination against tetanus (Holmes et al., 2006), cases are still 
being reported in equine hospitals in countries such as the USA where vaccination is widely 
available (Green et al., 1994). For this reason, a representation of the protection of the British 
equine population of this fatal but easily preventable disease is necessary. 
 
The unvaccinated subset of the equine population is potentially important in the propagation 
of endemic infectious diseases such as influenza and herpes virus. To the author‟s 
knowledge, there have been no previous investigations into the association between 
demographic factors and vaccination practices in the general equine population. This 
information, as well as a general preliminary description of British equine demography could 
be a valuable addition to the investigative artillery of an epidemiological team in the case of 
an outbreak of equine infectious disease.  
 
The aims of this present study are to give a preliminary overview of British equine 
demography and vaccination coverage from the results of an ongoing web-based 
questionnaire. Specifically, we wish to describe the association between equine influenza, 
tetanus and herpes vaccination practices amongst horse owners and carers and other 
demographic variables that we investigated in the questionnaire.  
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2.2 Materials and methods 
2.2.1 Data collection 
A cross-sectional study of British horse owners was initiated on the 16
th
 of November 2010 
and is currently ongoing.  A link to an online „Horse Owners Questionnaire‟ was publicised 
through the equestrian media, relevant equine websites and in e-mail lists from equine 
organisations. These included the National Equine Database (8,500 members with valid email 
addresses), World Horse Welfare (25,000 active emails), British Eventing (8,000 members), 
British Dressage (10,000 members), Endurance GB (1,800 members), BHS (40,000 email 
contacts, 60,000 website visitors), Horse and Hound (weekly readership 250,000). 
Questionnaires in English and Welsh were completed using an online survey tool (“survey 
monkey”).  
The participating websites and media invited readers to answer the questionnaire relating to 
horses under their care or management and stipulated that only one person per family answer 
the questionnaire.  The questionnaire contained 30 questions (23 of which were mandatory) 
relating to use of horses, location, travel, importation, vaccination horse owner age and sex 
and registration with the National Equine Database.  The questions had multiple choice 
answers, with the opportunity, where applicable, for the respondent to answer “other” and 
make a qualitative comment relating to this.  For some multiple choice questions, respondents 
could give more than one answer. E.g. if they kept their horse(s) in more than one type of 
premises, they could answer with all the premises that applied to them. 
The introductory message and full questionnaire are available on: 
http://www.surveymonkey.com/s/horseownersurvey 
Survey response 
A total of 4187 respondents participated in the survey between the 16
th
 of November 2010 
and the 10
th
 of March 2011, 4094 of which provided valid British post-codes. Seventy-nine 
respondents who failed to provide post-codes and 14 with post-codes from the crown 
dependencies and outside the UK were excluded (Table 2.1). The websites, media and e-mail 
addresses through which information about the questionnaire was dispersed had an estimated 
audience of 400,000 people. However, the size of the denominator population could not be 
calculated as the online nature of the questionnaire meant that there was unrestricted access 
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and there could be overlap between the audiences of different websites, media and e-mail 
addresses. 
When the data from the included and excluded respondents were compared, more excluded 
respondents were found to keep horses in livestock farms (P=0.03, OR=3, 95% CI 2.24-7.8 ) 
and racing yards (P<0.001, OR=15, 95% CI 3.34-67.91).  Also, there were no respondents 
between the ages of 45 and 54 years amongst the 11 excluded respondents who answered this 
question, compared to 919/3282 (28%) of included respondents. 
From this point, only results relating to the 4094 respondents with valid British post-codes 
will be reported.  
Table 2.1: Breakdown of included and excluded respondents who participated in the questionnaire 
between the 16
th
 of November 2010 and the 10
th
 of March 2011. (GB = Great Britain, PC = post code). 
 
Category  Number of respondents (%)  Horses associated with 
respondents (%) 
Valid GB PC  4094 (97.77%) 16676 (99.56%) 
No PC/invalid PC  79 (1.89%) 31 (0.19%) 
Belfast  5 (0.07%) 42 (0.25%) 
Guernsey  3 (0.07%) 5 (0.03%) 
Jersey  3 (0.07%) 10 (0.06%) 
Isle of Man  2 (0.05%) 5 (0.03%) 
Denmark  1 (0.02%) 4 (0.02%) 
Total  4187 (100%) 16750 (100%) 
 
2.2.2 Response rates to individual questions 
After the initial questions about post-code and address, 3988/4094 (97%) of respondents 
answered the initial mandatory question and 3277/4094 (80%) answered the final mandatory 
question in the questionnaire (excluding a separate section about the National Equine 
Database which had a 72% response rate). Non mandatory questions relating to international 
travel, countries that horses were imported from and reasons for importing shared a response 
rate of 3%, with 112, 115 and 112 respondents out of 4094 answering these questions 
respectively. For the non-mandatory questions relating to vaccination, 3188/4094 (78%) 
respondents answered and 2598/4094 answered a question about membership of equestrian 
societies. For the purposes of analysis of vaccination practice, true “missing” respondents‟ 
41 
 
answers were those which were also “missing” for the next mandatory question on the 
questionnaire. Respondents who omitted to answer the question about vaccination but 
answered the next mandatory question taken to have given a negative response to the 
vaccination questions. This subset accounted for 97 of 318, 160 and 2984 negative answers 
for influenza, tetanus and herpes vaccination respectively and raised the total number of 
responses to the vaccination questions to 3285.  
Figure 2.1: The percentage of respondents with valid British postcodes who answered each question in the 
questionnaire. Questions 1-3 related to the respondents’ post-codes and addresses. Questions 28-30 
related to the National Equine Database (outside the remit of this study.) Questions 19, 21 and 22 were 
non-mandatory questions relating to international travel, countries that horses were imported from and 
reasons for importing. Of the small number respondents (121 and 112 respectively) who answered that 
they travelled internationally with their horses and imported horses, 100% answered questions 19 and 21 
relating to these activities. Questions 23 and 24 were non-mandatory questions relating to vaccination and 
membership of equestrian societies (respectively). 
 
 
2.2.3 Data analysis 
2.2.3.1 Descriptive summary  
Only respondents who listed valid British post-codes were included in the main analysis. A 
descriptive summary of the responses to the questionnaire was produced. This included post 
code area and region of the respondent, numbers of horses associated with each respondent, 
details about where the horses were kept, passport issuing organizations, the respondents 
connection to the horses (e.g., owner rider, owner non-rider, professional etc), frequency and 
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distance horses were travelled for 21 possible equestrian activities, transport practices, 
international travel, imported horses, vaccination practices, membership of equestrian bodies, 
and owner sex and age. Descriptive summaries were also made of answers (number of horses 
owned, type of premises and respondent age and gender) in the questionnaires from the 
excluded respondents. These were compared using Mann-Whitney and Chi-squared tests (for 
continuous and categorical data respectively) to check for selection bias. 
2.2.3.2 Univariable analysis of the association between variables and vaccination practices 
Univariable binary logistic regression was used to test the association between demographic 
variables and influenza, tetanus and herpes vaccination. The categorical variables tested were 
type of premises, region, participitation in and travel to activities, the respondent‟s type of 
equestrian involvement, the area nets to the premises, international travel, importation and the 
age-group and gender of the respondent. The association between vaccination and the 
continuous variables number of horses owned, number of horses on the premises and 
maximum hours travelled to horse care, local and national events was also tested. Variables 
with likelihood ratio test P values ≤0.05 were considered to be statistically significant. 
Summary Figures illustrating variables associated with increased and reduced odds of the 
different types of vaccination were created showing the possible confounding associations 
between the variables.  The statistical packages Minitab version 16 and WINPEPI Compare2, 
version 1.45 (Abramson 2004) were used for analyses.  
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2.3 Results 
2.3.1 Sample characteristics 
2.3.1.1 Respondent demographics 
The highest number of respondents (667/4094, 16%) listed South West England post-codes. 
Fewest respondents (16/4094, 0.3%) listed London post-codes (Table 2.2). 
Table 2.2: Numbers and percentages of respondents who listed post-codes from each region and numbers 
and percentages of horses associated with these respondents. 
Region 
Respondents 
(%) Horses (%) 
South West England 667 (16.3) 2634 (15.8) 
East Anglia 525 (12.8) 1928 (11.6) 
South Central England 492 (12) 2156 (12.9) 
Midlands 480 (11.7) 1906 (11.4) 
North West England 462 (11.3) 1974 (11.8) 
North East England 451 (11) 1930 (11.6) 
Scotland 427 (10.4) 1751 (10.5) 
South East England 358 (8.7) 1281 (7.7) 
Wales 216 (5.3) 1051 (6.3) 
London 16 (0.4) 65 (0.4) 
Total 4094 16676 
The majority of respondents (3127/3284, 95%) were female and 70.2% were over the age of 
34. Numbers for each age group are listed on tables 2.7-2.9 with the vaccination analyses. 
Respondents over the age of 45 years owned significantly more horses than respondents 
under this age (P<0.001). The majority of respondents ( 3179/4497, 71%  answers given) 
were horse owners that also rode (tables 2.7-2.9). 
2.3.1.2 Demographics of horses associated with respondents 
Most respondents listed their own premises as where they kept their horse. Fewest listed a 
racing yard (Table 2.3).  
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Table 2.3: Types of premises where horses were kept. Some respondents gave more than one answer to 
this question, resulting in more answers (4895) than respondents (3951). 
Type of premises Respondents (%) Horses  (%) 
Own premises 1275 (26.3) 7256 (31.6) 
Livery yard  1252 (25.8) 4328 (18.8) 
Private yard 842 (17.4) 3116 (13.6) 
Livestock farm 496 (10.2) 2623 (11.4) 
Riding school  184 (3.8) 1652 (7.2) 
Rented pasture  358 (7.4) 1525 (6.6) 
Other premises 201 (4.1) 1423 (6.2) 
Arable farm  218 (4.5) 888 (3.9) 
Racing yard  19 (0.4) 159 (0.7) 
Total answers/horses associated 
with answers 4845 22970 
There were most horses per premises in riding schools (median 30, interquartile range (IQR) 
12-45) and fewest per premises at rented pasture (median 2, IQR 2-6). (Figure 2.2). Only 
19/3826 (0.5%) and 201/3876 (5.1%) of respondents stabled their horses entirely in summer 
and winter respectively, with 1916/3826 (49.4%) of respondents keeping their horses entirely 
outdoors in the summer. The majority (3205/4357, 73.5%) of respondents kept their horses 
2.5 miles or less from where they lived themselves.  
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Figure 2.2: Box plot showing median values and interquartile ranges for numbers of horses on different 
tyupes of premises. Whiskers represent upper and lower limits (maximum 1.5 inter-quartile range above 
and below quartiles)  
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Of 21 possible activities, most respondents (93.5%) claimed to participate in hacking or 
leisure riding. The numbers of respondents claiming to participate in each of the 21 activities 
are listed in Table 2.4. Respondents travelled a median of 1 hour for local events and horse 
care and a median of 2 hours to national events (Table 2.5). Most respondents (2166/4019, 
53.9%) transported their own horse in their own vehicle. However, 624/4019 (15.5%) of 
respondents transported their horses mixed with horses from different premises. Of 3297 
respondents, 1401 (42.5%) stated that their horses had spent nights away from home in the 
past year. Only 121/3295 (3.7%) respondents claimed to travel internationally with their 
horses and 112/3188 (3.5%) claimed to import horses. Most respondents who claimed to 
import (51/112, 45.5%) listed Ireland as the source of their imported horses. Germany, 
France, the Netherlands and Belgium were the next most listed countries for importation with 
17 (15.2%), 15 (13.4%) , 13  (11.6%) and 11( 9.8%)  respondents (respectively) listing these 
countries as the origins  for their imported horses.  
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Table 2.4: Numbers of respondents who participate in 21 possible activities. 
Activity 
Respondents who 
participate in 
activity 
% Total 
respondents 
Hacking  3240 93.5% 
Farrier  3153 91.0% 
Riding lessons 2253 65.0% 
Unaffiliated events  1973 56.9% 
Training  1930 55.7% 
Using facilities at a 
different premises 1885 54.4% 
Dressage  1791 51.7% 
Showing  1403 40.5% 
Show-jumping  1395 40.2% 
 Riding/pony club 1392 40.2% 
Affiliated events  1043 30.1% 
Hunting  807 23.3% 
Eventing  773 22.3% 
Endurance  633 18.3% 
Breeding  598 17.3% 
Other  518 14.9% 
Trailblazers  384 11.1% 
Driving  254 7.3% 
Western  163 4.7% 
Point-to-point 104 3.0% 
Vaulting  49 1.4% 
Total respondents 3466 100.0% 
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Table 2.5: Descriptive statistics for the time spent travelling for local and national events and for horse 
care (veterinary and farrier attention) by 3439 respondents who answered this question. 
 
Purpose of travel Total 
hours 
travel 
Mean 
hours 
travel 
Lower 
quartile 
Median 
hours 
travel 
Upper 
quartile 
Local events 6586 1.915 1 1 2 
National events 13157 3.826 0 2 4 
Horse Care 7875 2.29 1 1 2 
 
2.3.2 Vaccination 
2.3.2.1 Descriptive statistics 
Of 3285 respondents, 3174 (96.6%) vaccinated their horses against at least one of influenza, 
tetanus and herpes virus. In addition, 3 respondents vaccinated against West Nile Disease, 3 
against Equine Viral Arteritis, 2 against rabies and 1 against botulism. A further 4 
respondents believed that mite treatment, vitamin B supplementation and herbal remedies 
constituted vaccination. Although there was a question regarding strangles vaccination in the 
questionnaire, this was not analysed due as the strangles vaccine was withdrawn from the 
market between 2006 and 2011. The numbers of respondents who vaccinated against 
influenza, tetanus and herpes virus are summarised on Table 2.6. 
Table 2.6: Numbers and percentages of respondents who vaccinated their horses against influenza, 
tetanus and herpes virus. 
Type of vaccination 
Respondents who 
vaccinate (%) 
Respondents who 
don't vaccinate (%) 
Influenza 2967 (90.3) 318 (9.7) 
Tetanus 3125 (95.1) 160 (4.9) 
Herpes virus 301 (9.2) 2984 (90.8) 
Vaccination (any of above) 3174 (96.6) 111 (3.4) 
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2.3.2.2 Univariable analysis of factors associated with vaccination 
The results of univariable analyses into the associations between reported influenza, tetanus, 
herpes and any vaccination and region, the type of premises where horses were kept, 
engagement in and travel to any activity, type of activity, type of area adjacent to the 
premises where the respondent keeps their horse(s),  international travel, importation, the age 
and gender of the respondent, the number of horses owners, the number of horses on the same 
premises and the maximum hours travelled to equestrian events are listed in tables 2.7-2.9 
and summarised in Figures 2.3-2.9. A further table and diagram describing the association 
between demographic variables and any vaccination are listed in the appendix (Table A1 and 
Figures A.2 and A.3). The associations between the separate demographic variables that are 
associated with vaccination are also described (with odds ratios) in the appendix (Table. A.2).  
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Table 2.7: Description of the proportions of horses vaccinated and unvaccinated against equine influenza associated with demographic variables, including 
univariable odds ratios and likelihood ratio test P values of association with influenza vaccination. Blue and yellow highlighting denote decreased and increased 
odds (respectively) of a variable being associated with influenza vaccination. 
Variable 
Total Respondents (n=  
3285 who answered 
vaccination questions) 
Unvaccinated 
against influenza               
(%) 
Vaccinated 
against 
influenza                
(%) 
Coefficient 
Standard 
error of 
coefficient 
Wald P 
value 
Likelihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
Type of premises                   
 Arable farm 182 12 (6.6) 170 (93.4) 0.44 0.30 0.15 0.127 1.55 0.85-2.82 
 Livery yard 1040 51 (4.9) 989 (95.1) 0.96 0.16 <0.001 <0.001 2.62 1.92-3.57 
 Livestock farm 416 51 (12.3) 365 (87.7) -0.31 0.16 0.058 0.065 0.73 0.53-1.01 
 Other premises 170 16 (9.4) 154 (90.6) 0.03 0.27 0.903 0.903 1.03 0.61-1.75 
 Own premises 1072 141 (13.2) 931 (86.8) -0.56 0.12 <0.001 <0.001 0.57 0.45-0.73 
 Private yard 696 52 (7.5) 644 (92.5) 0.35 0.16 0.027 0.022 1.42 1.04-1.93 
 Racing yard 14 1 (7.1) 13  (92.9) 0.33 1.04 0.749 0.737 1.4 0.18-10.7 
 Rented pasture 315 47 (14.9) 268 (85.1) -0.56 0.17 0.001 0.002 0.57 0.41-0.8 
 Riding school 138 14 (10.1) 124 (89.9) -0.05 0.29 0.85 0.851 0.95 0.54-1.67 
Region                   
Midlands 372 23 (6.2) 349 (93.8)       0.01 1(REF)   
South Central England 385 25 (6.5) 360 (93.5) -0.05 0.30 0.861 0.861 0.95 0.53-1.7 
South East England 304 21 (6.9) 283 (93.1) -0.12 0.31 0.704 0.704 0.89 0.48-1.64 
East Anglia 427 30 (7) 397 (93) -0.14 0.29 0.633 0.632 0.87 0.5-1.53 
North West England 371 33 (8.9) 338 (91.1) -0.39 0.28 0.164 0.16 0.68 0.39-1.17 
London 11 1 (9.1) 10 (90.9) -0.42 1.07 0.697 0.82 0.66 0.08-5.37 
Scotland 347 34 (9.8) 313 (90.2) -0.50 0.28 0.075 0.073 0.61 0.35 -1.05 
North East England 367 38 (10.4) 329 (89.6) -0.56 0.28 0.041 0.038 0.57 0.33-0.98 
South West England 527 77 (14.6) 450 (85.4) -0.95 0.25 <0.001 <0.001 0.39 0.24-0.63 
Wales 174 36 (20.7) 138 (79.3) -1.38 0.29 <0.001 <0.001 0.25 0.14-0.44 
Activities                   
Participates in at least 1 activity 3265 313 (9.6) 2952 (90.4)             
No activities 20   5 (25)   15 (75) -1.15 0.52 0.03 0.05 0.32 0.11-0.88 
                    
Travels to activities 2860 223(7.8) 2637(92.2)             
Does not travel 425 95(22.4) -77.6 -1.23 0.14 0.00 0.00 0.29 0.23-0.38 
                    
Affilliated competitions 999 35 (4) 964 (96) 1.35879 0.183416 <0.001 <0.001 3.89 2.72-5.57 
Unaffilliated competitions 1870 98 (5) 1772 (95) 1.20262 0.127084 <0.001 <0.001 3.33 2.59-4.27 
Hacking 3069 263 (9) 2806 (91) 1.29329 0.168972 <0.001 <0.001 3.64 2.62-5.08 
Hunting 756 45 (6) 711 (94) 0.648133 0.166538 <0.001 <0.001 1.91 1.38-2.65 
Breeding 569 63 (11) 506 (89) -0.183658 0.14892 0.217 0.224 0.83 0.62-1.11 
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Variable 
Total Respondents (n=  
3285 who answered 
vaccination questions) 
Unvaccinated 
against influenza               
(%) 
Vaccinated 
against 
influenza                
(%) 
Coefficient 
Standard 
error of 
coefficient 
Wald P 
value 
Likelihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
Dressage 2699 69 (3) 2630 (97) 1.9599 0.140132 <0.001 <0.001 7.1 5.39-9.34 
Trailblazers 359 16 (4) 343 (96) 0.903114 0.262884 0.001 <0.001 2.47 1.47-4.13 
Show jumping 1314 63 (5) 1251 (95) 1.08208 0.145522 <0.001 <0.001 2.95 2.22-3.92 
Eventing 728 25 (3) 703 (97) 1.29177 0.212784 <0.001 <0.001 3.64 2.4-5.52 
Endurance 604 36 (6) 568 (94) 0.617702 0.183033 0.001 <0.001 1.85 1.3-2.65 
Driving 239 33 (14) 206 (86) -0.43949 0.197556 0.026 0.033 0.64 0.44-0.95 
Western 156 19 (12) 137 (88) -0.272046 0.252247 0.281 0.296 0.76 0.46-1.25 
Showing 1326 99 (7) 1227 (93) 0.444639 0.126716 <0.001 <0.001 1.56 1.22-2 
vaulting 44 2 (5) 42 (95) 0.819215 0.726165 0.259 0.2 2.27 0.55-9.42 
Point-to-point 97 6 (6) 91 (94) 0.497948 0.425685 0.242 0.209 1.65 0.71-3.79 
Riding 1318 56 (4) 1262 (96) 1.24213 0.151832 <0.001 <0.001 3.46 2.57-4.66 
Lessons 2134 110 (5) 2024 (95) 1.40082 0.124307 <0.001 <0.001 4.06 3.18-5.18 
Farrrier 2992 272 (9) 2720 (91) 0.621838 0.172718 <0.001 0.001 1.86 1.33-2.61 
Facilities 1785 83 (5) 1702 (95) 1.33748 0.132972 <0.001 <0.001 3.81 2.94-4.94 
lessons 1835 97 (5) 1738 (95) 1.16999 0.127369 <0.001 <0.001 3.22 2.51-4.14 
Other activities 496 45 (9) 451 (91) 0.083851 0.168819 0.619 0.617 1.09 0.78-1.51 
Respondents' type of equestrian involvement                   
Breeder 269 44 (16.4) 225 (83.6) -0.67 0.18 <0.001 <0.001 0.51 0.36-0.72 
Donkey owner 41 10 (24.4) 31 (75.6) -1.12 0.37 0.002 0.006 0.33 0.16-0.67 
Livery yard proprietor 103 9 (8.7) 94 (91.3) 0.12 0.35 0.743 0.739 1.12 0.56-2.25 
Member travelling community 3 0 3 (100) 20.16 25553.20 0.999 nc ∞ 0-∞ 
Non-owner that loans/rides 80 13 (16.3) 67 (83.8) -0.61 0.31 0.047 0.063 0.54 0.3-0.99 
Other 490 55 (11.2) 435 (88.8) -0.33 0.24 0.176 0.192 0.72 0.45-1.16 
Owner non rider 220 50 (22.7) 170 (77.3) -1.12 0.17 <0.001 <0.001 0.33 0.23-0.46 
Owner that rides 2940 251 (8.5) 2689 (91.5) 0.95 0.15 <0.001 <0.001 2.58 1.92-3.47 
Professional 298 17 (5.7) 281 (94.3) 0.62 0.26 0.016 0.009 1.85 1.12-3.07 
Thoroughbred industry employee 25 3(12) 22 (88) -0.24 0.62 0.694 0.703 0.78 0.23-2.64 
Area next to premises                   
Coastal 73 10 (13.7) 63 (86.3) -0.40 0.35 0.243 0.265 0.67 0.34-1.32 
Grazing 2770 268 (9.7) 2502 (90.3) 0.00 0.16 0.981 0.981 1 0.73-1.38 
Hay 1145 93 (8.1) 1052 (91.9) 0.28 0.13 0.028 0.025 1.33 1.03-1.71 
Industrial 69 3 (4.3) 66(95.7) 1.28 0.72 0.076 0.093 3.58 0.87-14.7 
Other 490 55 (11.2) 435 (88.8) -0.20 0.16 0.211 0.219 0.82 0.6-1.12 
Running water 765 70 (9.2) 695 (90.8) 0.08 0.14 0.571 0.596 1.08 0.82-1.43 
Semirural 728 52 (7.1) 676 (92.9) 0.41 0.16 0.009 0.007 1.51 1.11-2.06 
Standing water 383 26 (6.8) 357 (93.2) 0.43 0.21 0.043 0.033 1.54 1.01-2.33 
Urban 177 14 (7.9) 163 (92.1) 0.23 0.28 0.414 0.4 1.26 0.72-2.21 
Woodland 1283 111 (8.7) 1172 (91.3) 0.20 0.12 0.111 0.108 1.22 0.96-1.55 
Missing 198                 
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Variable 
Total Respondents (n=  
3285 who answered 
vaccination questions) 
Unvaccinated 
against influenza               
(%) 
Vaccinated 
against 
influenza                
(%) 
Coefficient 
Standard 
error of 
coefficient 
Wald P 
value 
Likelihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
          International travel                   
No international travel 3165 314 (9.9) 2851 (90.1)         REF 1   
International travel 120 4 (3.3) 116 (96.7) 1.16 0.51 0.023 0.006 3.19 1.17 - 8.31 
Imports                   
Respondent doesn't import 2998 305 (10.2) 2693(89.8)         REF1   
Respondent imports 112 8 (7.1) 104 (92.9) 0.39 0.37 0.298 0.273 1.47 0.71 - 3.05 
Respondent age-group                   
16 to 24 years old 404 22 (5.4) 382 (94.6)       0.001 REF 1   
Under 16 years old 46 3 (6.5) 43 (93.5) -0.19 0.64 0.763 0.441 0.83 0.24-2.87 
25 to 34 years old 519 32 (6.2) 487 (93.8) -0.13 0.29 0.644 0.002 0.88 0.5-1.53 
35 to 44 years old 721 65 (9) 656 (91) -0.54 0.25 0.033 0.491 0.58 0.35-0.96 
45 to 54 years old 919 98 (10.7) 821 (89.3) -0.73 0.24 0.003 0.239 0.48 0.3-0.78 
55 years or older 673 98 (14.6) 575 (85.4) -1.08 0.24 <0.001 <0.001 0.34 0.21-0.55 
Respondent gender                   
Female 3127 299 (9.6) 2828 (90.4)          REF 1   
Male 158 19 139 -0.26 0.25 0.31 0.31 0.77 0.47-1.27 
Horses owned                   
Odds change per  extra horse owned       -0.02 0.01 0.002 0.003 0.98 0.97-0.99 
Horses on premises                   
Odds change per extra horse on premises       0.01 0.00 0.004 0.002 1.01 1-1.02 
Maximum number of hours travelled                   
Odds change per extra hour travelled to horse care       0.00 0.01 0.593 0.607 1 0.98-1.01 
Odds change per extra hour travelled to local events       0.05 0.03 0.076 0.014 1.05 0.99-1.12 
Odds change per extra hour travelled to national 
events       0.06 0.02 0.008 <0.001 1.06 1.02-1.11 
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Table 2.8: Description of the proportions of horses vaccinated and unvaccinated against tetanus associated with demographic variables, including univariable odds 
ratios and likelihood ratio test P values of association with tetanus vaccination. Blue and yellow highlighting denote decreased and increased odds (respectively) of a 
variable being associated with tetanus vaccination. 
Variable 
Total Respondents ( n=  3285 who 
answered vaccination questions) 
Unvaccinated against 
tetanus                (%) 
Vaccinated against 
tetanus                (%) 
Coefficient 
Standard 
error of 
coefficient 
Wald 
P 
value 
Liklihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
Type of premises                   
 Arable farm 182 7 (3.9) 175 (96.1) 0.26 0.39 0.51 0.494 1.3 0.6-2.81 
 Livery yard 1040 39 (3.8) 1001 (96.2) 0.38 0.19 0.043 0.038 1.46 1.01-2.11 
 Livestock farm 416 27 (6.5)  389 (93.5) -0.36 0.22 0.102 0.115 0.7 0.46-1.07 
 Other premises 170 8 (4.7) 162 (95.3) 0.04 0.37 0.918 0.918 1.04 0.5-2.15 
 Own premises 1072 46 (4.3) 1026 (95.7) 0.19 0.18 0.283 0.278 1.21 0.85-1.72 
 Private yard 696 33 (4.7) 663 (95.3) 0.04 0.20 0.858 0.858 1.04 0.7-1.53 
 Racing yard 14 1 (7.1) 13 (92.9) -0.41 1.04 0.694 0.71 0.66 0.09-5.11 
 Rented pasture only 315 22 (7) 293 (93) -0.43 0.24 0.069 0.082 0.65 0.41-1.03 
 Riding school 138 11 (8) 127 (92) -0.56 0.33 0.088 0.11 0.57 0.3-1.09 
Missing 143                 
Region                   
Midlands 372 12 (3.2) 360 (96.8)         REF 1   
East Anglia 427 21 (4.9) 406 (95.1) -0.44 0.37 0.227 0.227 0.64 0.31-1.33 
London 11 1 (9.1) 10 (90.9) -1.10 1.09 0.375 0.365 0.33 0.04-2.82 
North East England 367 14 (3.8) 353 (96.2) -0.17 0.40 0.664 0.664 0.84 0.38-1.84 
North West England 371 22 (5.9) 349 (94.1) -0.64 0.37 0.082 0.076 0.53 0.26-1.08 
Scotland 347 24 (6.9) 323 (93.1) -0.80 0.36 0.027 0.022 0.45 0.22-0.91 
South Central England 385 17 (4.4) 368 (95.6) -0.33 0.38 0.396 0.393 0.72 0.34-1.53 
South East England 304 12 (3.9) 292 (96.1) -0.21 0.42 0.615 0.615 0.81 0.36-1.83 
South West England 527 25 (4.7) 502 (95.3) -0.40 0.36 0.262 0.253 0.67 0.33-1.35 
Wales 174 12 (6.9) 162 (93.1) -0.80 0.42 0.057 0.059 0.45 0.2-1.02 
Activities                   
Participates in at least 1 activity 3265 159 (4.9) 3106 (95.1)             
No activities 20 1(5) 19 (95) -0.03 1.03 0.98 0.98 0.97 0.13-7.31 
Travels to activities 2860 123(4.3) 2737(95.7)             
Does not travel 425 37(8.7) 388(91.3) -0.75 0.20 0.00 0.00 0.47 0.32-0.69 
Affilliated competitions 999 25 (3) 974 (97) 0.894122 0.221131 <0.001 <0.001 2.45 1.59-3.77 
Unaffilliated competitions 1870 57 (3) 1813 (97) 0.915108 0.169015 <0.001 <0.001 2.5 1.79-3.48 
Hacking 3069 133 (4) 2936 (96) 1.14854 0.224025 <0.001 <0.001 3.15 2.03-4.89 
Hunting 756 27 (4) 729 (96) 0.40463 0.215279 0.06 0.05 1.5 0.98-2.29 
Breeding 569 22 (4) 547 (96) 0.282406 0.234341 0.228 0.208 1.33 0.84-2.1 
Dressage 1699 48 (3) 1651 (97) 0.960699 0.176197 <0.001 <0.001 2.61 1.85-3.69 
Trailblazers 359 13 (4) 346 (96) 0.342076 0.294917 0.246 0.225 1.41 0.79-2.51 
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Variable 
Total Respondents ( n=  3285 who 
answered vaccination questions) 
Unvaccinated against 
tetanus                (%) 
Vaccinated against 
tetanus                (%) 
Coefficient 
Standard 
error of 
coefficient 
Wald 
P 
value 
Liklihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
Show jumping 1314 48 (4) 1266 (96) 0.463121 0.176323 0.009 0.007 1.59 1.12-2.25 
Eventing 728 21 (3) 707 (97) 0.660286 0.237993 0.006 0.003 1.94 1.21-3.09 
Endurance 604 15 (2) 589 (98) 0.808766 0.275055 0.003 0.001 2.25 1.31-3.85 
Driving 239 10 (4) 229 (96) 0.170686 0.333735 0.609 0.601 1.19 0.62-2.28 
Western 156 10 (6) 146 (94) -0.307686 0.337419 0.362 0.381 0.74 0.38-1.42 
Showing 1326 41 (3) 1285 (97) 0.706545 0.184703 <0.001 <0.001 2.03 1.41-2.91 
vaulting 44 1 (2) 43 (98) 0.79677 1.01482 0.432 0.371 2.22 0.3-16.21 
Point-to-point 97 5 (5) 92 (95) -0.0615317 0.46653 0.895 0.896 0.94 0.38-2.35 
Riding 1318 35 (3) 1283 (97) 0.911315 0.19466 <0.001 <0.001 2.49 1.7-3.64 
Lessons 2134 77 (4) 2057 (96) 0.730496 0.162658 <0.001 <0.001 2.08 1.51-2.86 
Farrrier 2992 139 (5) 2853 (95)  0.460373 0.24257 0.058 0.056 1.58 0.99-2.55 
Facilities 1785 51 (3) 1734 (97) 0.97993 0.173428 <0.001 <0.001 2.66 1.9-3.74 
lessons 1835 57 (3) 1778 (97) 0.869287 0.168989 <0.001 <0.001 2.39 1.71-3.32 
Other activities 496 14 (3) 482 (97) 0.642823 0.284129 0.024 0.014 1.9 1.09-3.32 
Respondents' type of equestrian involvement                 
Breeder 269 17 (6.3) 252 (93.7) -0.30 0.26 0.251 0.268 0.74 0.44-1.24 
Donkey owner 41 3 (7.3) 38 (92.7) -0.44 0.61 0.468 0.494 0.64 0.2-2.11 
Livery yard proprietor 103 6 (5.8) 97 (94.2) -0.20 0.43 0.648 0.657 0.82 0.35-1.91 
Member travelling community 3 0 3 (100) 20.08 35466.70 1 nc ∞ 0-∞ 
Non-owner that loans/rides 80 11 (13.8) 69 (86.3) -1.18 0.34 0 0.002 0.31 0.16-0.59 
Other 490 22 (4.5) 468 (95.5) 0.32 0.42 0.452 0.431 1.38 0.6-3.16 
Owner non rider 220 19 (8.6) 201 (91.4) -0.67 0.26 0.008 0.014 0.51 0.31-0.84 
Owner that rides 2940 125 (4.3) 2815 (95.7) 0.93 0.20 <0.001 <0.001 2.54 1.72-3.77 
Professional 298 6 (2) 292 (98) 0.97 0.42 0.021 0.0007 2.65 1.16-6.03 
Thoroughbred industry employee 25 1 (4) 24 (96) 0.21 1.02 0.839 0.834 1.23 0.17-9.15 
Area next to premises                   
Coastal 73 7 (9.6) 66 (90.4) -0.75 0.41 0.064 0.091 0.47 0.21-1.05 
Grazing 2770 129 (4.7) 2641 (95.3) 0.27 0.21 0.188 0.2 1.31 0.88-1.96 
Hay 1145 52 (4.5) 1093 (95.5) 0.11 0.17 0.522 0.519 1.12 0.8-1.57 
Industrial 69 3 (4.3) 66 (95.7) 0.12 0.60 0.839 0.836 1.13 0.35-3.63 
Other 490 22 (4.5) 468 (95.5) 0.10 0.23 0.671 0.668 1.1 0.7-1.75 
Running water 765 33 (4.3) 732 (95.7) 0.16 0.20 0.414 0.408 1.18 0.8-1.74 
Semirural 728 34 (4.7 ) 694 (95.3) 0.06 0.20 0.776 0.775 1.06 0.72-1.56 
Standing water 383 14 (3.7) 369 (96.3) 0.33 0.29 0.242 0.222 1.4 0.8-2.44 
Urban 177 9 (5.1) 168 (94.9) -0.05 0.35 0.892 0.892 0.95 0.48-1.9 
Woodland 1283 45 (3.5) 1238 (96.5) 0.52 0.18 0.004 0.003 1.68 1.18-2.38 
International travel                   
No international travel 3165 158 (5) 3007 (95)         REF 1   
International travel 120 2 (1.7) 118 (98.3) 1.13 0.72 0.115 0.057 3.1 0.76 - 12.66 
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Variable 
Total Respondents ( n=  3285 who 
answered vaccination questions) 
Unvaccinated against 
tetanus                (%) 
Vaccinated against 
tetanus                (%) 
Coefficient 
Standard 
error of 
coefficient 
Wald 
P 
value 
Liklihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
Imports                   
Respondent doesn't import 2998 148 (4.9) 2850 (95.1)         REF 1   
Respondent imports 112 4 (3.6) 108 (96.4) 0.34 0.52 0.513 0.491 1.4 0.51-3.86 
Respondent age-group                   
45 to 54 years old 919 36 (3.9) 883 (96.1)       0.106 REF 1   
35 to 44 years old 721 33 (4.6) 688 (95.4) -0.16 0.25 0.509 0.676 0.85 0.52-1.38 
25 to 34 years old 519 25 (4.8) 494 (95.2) -0.22 0.27 0.417 0.951 0.81 0.48-1.36 
55 years or older 673 35 (5.2) 638 (94.8) -0.30 0.24 0.222 0.659 0.74 0.46-1.2 
16 to 24 years old 404 26 (6.4) 378 (93.6) -0.52 0.26 0.048 0.133 0.59 0.35-1 
Under 16 years old 46 5 (10.9) 41 (89.1) -1.10 0.50 0.029 0.098 0.33 0.12-0.9 
Respondent gender                   
Female 3127 140 (4.5) 2987 (95.5)         REF 1   
Male 158 20 (12.7) 138 (87.3) -1.13 0.25 <0.001 <0.001 0.32 0.2-0.53 
Horses owned                   
Odds change per  extra horse owned       -0.01 0.01 0.14 0.18 0.99 0.97-1 
Horses on premises                   
Odds change per extra horse on 
premises       0.00 0.01 0.93 0.93 1.00 0.99-1.01 
Maximum number of hours travelled                 
Odds change per extra hour travelled to horse care     -0.01 0.01 0.12 0.10 0.99 0.97-1 
Odds change per extra hour travelled to local events     0.07 0.05 0.16 0.04 1.08 0.97-1.19 
Odds change per extra hour travelled to national events   0.15 0.04 <0.001 <0.001 1.16 1.08-1.26 
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Table 2.9: Description of the proportions of horses vaccinated and unvaccinated against equine herpes virus associated with demographic variables, including 
univariable odds ratios and likelihood ratio test P values of association with influenza vaccination. Blue and yellow highlighting denote decreased and increased 
odds (respectively) of a variable being associated with tetanus vaccination. 
Variable 
Total Respondents (n=  3285 
who answered vaccination 
questions) 
Unvaccinated 
against herpes             
(%) 
Vaccinated 
against herpes               
(%) 
Coefficient 
Standard error 
of coefficient 
Wald P 
value 
Likelihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
Type of premises                   
 Arable farm 182 170 (93.4) 12 (6.6) -4.93 0.31 0.219 0.196 0.69 0.38-1.25 
Livery yard 1040 920 (88.5) 120 (11.5) 0.40 0.12 0.001 0.002 1.49 1.17-1.9 
 Livestock farm 416 390 (93.8) 26 (6.2) -0.46 0.21 0.029 0.021 0.63 0.41-0.95 
 Other premises 170 151 (88.8) 19 (11.2) 0.23 0.25 0.351 0.364 1.26 0.77-2.07 
 Own premises 1072 987 (92) 85 (8) -0.23 0.13 0.089 0.084 0.8 0.61-1.03 
 Private yard 696 625 (89.8) 71 (10.2) 0.15 0.14 0.285 0.291 1.17 0.88-1.54 
 Racing yard 14 12 (85.7) 2 (14.3) 0.50 0.77 0.51 0.535 1.66 0.37-7.44 
 Rented pasture only 315 289 (91.8) 26 (8.2) -0.13 0.21 0.557 0.551 0.88 0.58-1.34 
 Riding school 138 125 (90.6) 13 (9.4) 0.03 0.30 0.915 0.915 1.03 0.58-1.85 
Region                   
East Anglia 427 375 (87.8) 52 (12.2)         REF 1   
London 11 9 (81.9) 2 (18.2) 0.47 0.80 0.553 0.895 1.6 0.34-7.62 
Midlands 372 339 (91.1) 33 (8.9) -0.35 0.23 0.132 0.129 0.7 0.44-1.11 
North East England 367 328 (89.4) 39 (10.6) -0.15 0.22 0.494 0.493 0.86 0.55-1.33 
North West England 371 340 (91.6) 31 (8.4) -0.42 0.24 0.079 0.076 0.66 0.41-1.05 
Scotland 347 329 (94.8) 18 (5.2) -0.93 0.28 0.001 0.001 0.39 0.23-0.69 
South Central England 385 342 (88.8) 43 (11.2) -0.10 0.22 0.655 0.655 0.91 0.59-1.39 
South East England 304 275 (90.5) 29 (9.5) -0.27 0.24 0.264 0.259 0.76 0.47-1.23 
South West England 527 486 (92.2) 41 (7.8) -0.50 0.22 0.024 0.023 0.61 0.4-0.94 
Wales 174 161 (92.5) 13 (7.5) -0.54 0.32 0.095 0.082 0.58 0.31-1.1 
Activities                   
Participates in at least 1 activity 3265 2966(90.8) 299(9.2)             
No activities 20 18(90) 2(10) 0.10 0.75 0.90 0.90 1.1 0.25-4.77 
                    
Travels to activities 2860 2588(90.5) 272(9.5)             
Does not travel 425 396(93.2) 29(6.82) -0.36 0.20 0.08 0.07 0.7 0.47-1.04 
                    
Affilliated competitions 999 875 (88) 124 (12) 0.523877 0.123819 <0.001 <0.001 1.69 1.32-2.15 
Unaffilliated competitions 1870 1671 (89) 199 (11) 0.427224 0.127236 0.001 0.001 1.53 1.19-1.97 
Hacking 3069 2783 (91) 286 (9) 0.319962 0.274768 0.244 0.225 1.38 0.8-2.36 
Hunting 756 672 (89) 84 (11) 0.286529 0.135771 0.035 0.038 1.33 1.02-1.74 
Breeding 569 480 (84) 89 (16)  0.783909 0.135777 <0.001 <0.001 2.19 1.68-2.86 
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Variable 
Total Respondents (n=  3285 
who answered vaccination 
questions) 
Unvaccinated 
against herpes             
(%) 
Vaccinated 
against herpes               
(%) 
Coefficient 
Standard error 
of coefficient 
Wald P 
value 
Likelihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
Dressage 1699 1518 (89) 181 (11) 0.376149 0.123285 0.002 0.002 1.46 1.14-1.85 
Trailblazers 359 322 (90) 37 (10) 0.14725 0.185192 0.427 0.433 1.16 0.81-1.67 
Show jumping 1314 1178 (90) 136 (10) 0.234006 0.121721 0.055 0.055 1.26 1-1.6 
Eventing 728 641 (88) 87 (12) 0.39609 0.134737 0.003 0.004 1.49 1.14-1.94 
Endurance 604 540 (89) 64 (11) 0.200645 0.148679 0.177 0.184 1.22 0.91-1.64 
Driving 239 217 (91) 22 (9) 0.0054523 0.232396 0.981 0.981 1.01 0.64-1.59 
Western 156 137 (88) 19 (12) 0.336572 0.252642 0.183 0.199 1.4 0.85-2.3 
Showing 1326 1186 (89) 140 (11) 0.276327 0.121463 0.023 0.023 1.32 1.04-1.67 
vaulting 44 32 (73) 12 (27) 1.34298 0.344067 <0.001 <0.001 3.83 1.95-7.52 
Point-to-point 97 80 (82) 17 (18) 0.776057 0.274206 0.005 0.009 2.17 1.27-3.72 
Riding 1318 1197 (91) 121 (9) 0.0035535 0.123349 0.977 0.977 1 0.79-1.28 
Lessons 2134 1931 (90) 203 (10) 0.121844 0.128832 0.344 0.432 1.13 0.88-1.45 
Farrrier 2992 2711 (91) 281 (9) 1.04017 0.32801 0.002 0.131 2.83 1.49-5.38 
Facilities 1785 1619 (91) 166 (9) 0.0360588 0.12158 0.767 0.767 1.04 0.82-1.32 
lessons 1865 1699 (91) 166 (9) -
0.0494902 
0.121575 0.684 0.795 0.95 0.75-1.21 
Other activities 496 451 (91) 45 (9) -
0.0128226 
0.16953 0.94 0.94 0.99 0.71-1.38 
Respondents' type of equestrian involvement                   
Breeder 269 229 (85.1) 40 (14.9) 0.61 0.18 0.001 0.002 1.84 1.29-2.64 
Donkey owner 41 40 (97.6) 1 (2.4) -1.41 1.01 0.166 0.079 0.25 0.03-1.79 
Livery yard proprietor 103 89 (86.4) 14 (13.6) 0.46 0.29 0.116 0.136 1.59 0.89-2.82 
Member travelling community 3 2 (66.7) 1 (33.3) 1.60 1.23 0.191 nc 4.97 0.45-54.97 
Non-owner that loans/rides 80 65 (81.3) 15 (18.8) 0.86 0.29 0.003 0.007 2.36 1.33-4.18 
Other 490 452 (92.2) 38 (7.8) 0.39 0.24 0.106 0.121 1.48 0.92-2.38 
Owner non rider 220 200 (90.9) 20 (9.1) -0.01 0.24 0.969 0.969 0.99 0.62-1.59 
Owner that rides 2940 2679 (91.1) 261 (8.9) -0.30 0.18 0.099 0.109 0.74 0.52-1.06 
Professional 298 263 (88.3) 35 (11.7) 0.31 0.19 0.106 0.118 1.36 0.94-1.98 
Thoroughbred industry employee 25 20 (80) 5 (20) 0.92 0.50 0.068 0.097 2.5 0.93-6.72 
Missing 523                 
Area next to premises                   
Coastal 73 63 (86.3) 10 (13.7) 0.47 0.35 0.178 0.202 1.59 0.81-3.14 
Grazing 2770 2514 (90.8) 256 (9.2) 0.06 0.17 0.716 0.714 1.06 0.76-1.48 
Hay 1145 1039 (90.7) 106 (9.3) 0.02 0.13 0.89 0.891 1.02 0.79-1.3 
Industrial 69 60 (87) 9 (13) 0.41 0.36 0.262 0.285 1.5 0.74-3.06 
Other 490 452 (92.2) 38 (7.8) -0.21 0.18 0.242 0.232 0.81 0.57-1.15 
Running water 765 701 (91.6) 64 (8.4) -0.13 0.15 0.383 0.379 0.88 0.66-1.17 
Semirural 728 647 (88.9) 81 (11.1) 0.29 0.14 0.038 0.042 1.33 1.02-1.74 
Standing water 383 353 (92.2) 30 (7.8) -0.19 0.20 0.338 0.327 0.83 0.56-1.22 
Urban 177 160 (90.4) 17 (9.6) 0.05 0.26 0.834 0.835 1.06 0.63-1.77 
Woodland 1283 1169 (91.1) 114 (8.9) -0.05 0.12 0.659 0.659 0.95 0.74-1.21 
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Variable 
Total Respondents (n=  3285 
who answered vaccination 
questions) 
Unvaccinated 
against herpes             
(%) 
Vaccinated 
against herpes               
(%) 
Coefficient 
Standard error 
of coefficient 
Wald P 
value 
Likelihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
International travel                   
No international travel 3165 2890 (91.3) 275 (8.7)         REF 1   
International travel 120 94 (78.3) 26 (21.7) 1.07 0.23 <0.001 <0.001 2.91 1.85 -4.57 
Imports                   
Respondent doesn't import 2998 2734 (91.2) 264 (8.8)         REF 1   
Respondent imports 112 93 (83) 19 (17) 0.75 0.26 0.004 0.007 2.12 1.27-3.52 
Respondent age-group                   
Under 16 years old 46 27 (58.7) 19 (41.3)       <0.001 REF 1   
25 to 34 years old 519 461 (88.8) 58 (11.2) -1.72 0.33 <0.001 0.091 0.18 0.09-0.34 
16 to 24 years old 404 362 (89.4) 42 (10.4) -1.80 0.34 <0.001 0.367 0.16 0.08-0.32 
35 to 44 years old 721 658 (91.3) 63 (8.7) -1.99 0.33 <0.001 0.653 0.14 0.07-0.26 
55 years or older 673 621 (92.3) 52 (7.7) -2.13 0.33 <0.001 0.14 0.12 0.06-0.23 
45 to 54 years old 919 853 (92.8) 66 (7.2) -2.21 0.33 <0.001 0.012 0.11 0.06-0.21 
Respondent gender                   
Female 3127 2848 (91.1) 279 (8.9)         REF 1   
Male 158 136 (86.1) 22 (13.9) 0.50 0.24 0.035 0.074 1.65 1.04-2.63 
Horses owned                   
Odds change per  extra horse owned       0.03 0.01 <0.001 <0.001 1.03 1.01-1.04 
                    
Horses on premises                   
Odds change per extra horse on premises       0.01 0.00 <0.001 <0.001 1.01 1.01-1.02 
                    
Maximum number of hours travelled                   
Odds change per extra hour travelled to horse care       0.01 0.01 0.062 0.087 1.01 1-1.03 
Odds change per extra hour travelled to local events       0.01 0.01 0.443 0.467 1.01 0.99-1.03 
Odds change per extra hour travelled to national 
events       0.00 0.00 0.207 0.025 1 1-1.01 
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Figure 2.3: The demographic variables which were associated with reduced odds of influenza vaccination 
(with 95% confidence intervals less than 1). The arrows between variables represent associations between 
them (the presence of one variable increasing the odds of the presence of the other with 95% confidence 
intervals for odds ratios greater than 1). 
 
 
 
 
 
 
 
 
 
 
] 
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Figure 2.4: The variables which were associated with increased odds of influenza vaccination (with 95% 
confidence intervals greater than 1). The arrows between variables represent associations between them 
(the presence of one variable increasing the odds of the presence of the other with an odds ratio with 95% 
confidence intervals greater than 1). The activities highlighted in brown are those associated with 
respondents that listed “Riding instructor/coach/professional” as describing their involvement with 
horses. Affilliated competitive activities were associated with extra hours r=travelled to national events 
and private yards.  
 
 
 
Activities: affiliated, 
unaffiliated, hacking, 
hunting, eventing, 
endurance, dressage, 
show-jumping, trailblazers, 
riding/pony club, lessons . 
Increased odds of flu 
vaccination 
Owner that rides 
Livery yard 
International 
travel 
Professional 
Horse kept 
adjacent to hay, 
semi-rural area or 
standing water Extra hours travelled to 
national events 
Private yard 
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Figure 2.5: The variables which were associated with reduced odds of tetanus vaccination (with 95% 
confidence intervals less than 1). The arrows between variables represent associations between them (the 
presence of one variable increasing the odds of the presence of the other with an odds ratio with 95% 
confidence intervals greater than 1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
61 
 
Figure 2.6: The variables which were associated with increased odds of tetanus vaccination (with 95% 
confidence intervals greater than 1). The arrows between variables represent associations between them 
(the presence of one variable increasing the odds of the presence of the other with an odds ratio with 95% 
confidence intervals greater than 1). The activities highlighted in yellow are those associated with 
respondents that listed “Riding instructor/coach/professional” as describing their involvement with 
horses. 
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Figure 2.7: The variables which were associated with reduced odds of herpes vaccination (with 95% 
confidence intervals less than 1). The arrows between variables represent associations between them (the 
presence of one variable increasing the odds of the presence of the other with an odds ratio with 95% 
confidence intervals greater than 1). 
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Figure 2.8: The variables which were associated with increased odds of herpes vaccination (with 95% 
confidence intervals greater than 1). The arrows between variables represent associations between them 
(the presence of one variable increasing the odds of the presence of the other with an odds ratio with 95% 
confidence intervals greater than 1). The activities highlighted in yellow are those associated with 
respondents that listed “Riding instructor/coach/professional professional” as describing their 
involvement with horses. International travel is associated with affiliated activities. Affiliated activities, 
hunting, breeding and dressage are associated with importing horses. 
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2.4 Discussion 
 
2.4.1 Advantages and disadvantages of the web-based format and consideration of bias 
In previous studies, horse owners registered with veterinary practices functioned as the 
sample population for questionnaires relating to equine demographics and management 
practices (Hotchkiss et al., 2007; Ireland et al., 2011; Mellor et al., 1999). It is likely that 
owners registered with veterinary practices are more likely to vaccinate their horses that those 
that are not. Given the primary aim of this study was to investigate the association between 
demographic variables and vaccination practices, the web-based nature of this present 
questionnaire was advantageous in avoiding selection bias associated with owners registered 
with veterinary practices. 
 
According to the Office of National Statistics in 2008, 65% of households in the UK have 
internet access (Anon, 2008), indicating that the web is a powerful resource for conducting 
health surveys (Fischbacher et al., 2000). The web-based format also facilitated a large 
sample size and efficient transfer of questionnaire responses to a database for analysis. The 
broad web audience has enabled the inclusion of respondents from every region in Great 
Britain and a description of the numbers of respondents from each region. This was not 
possible in the targeted postal questionnaires of (Hotchkiss et al., 2007) and (Mellor et al., 
1999).  
 
A disadvantage of a web-based format is that the non-response rate cannot be calculated due 
to the open-access nature of the questionnaire. I.e. it is impossible to know how many horse 
owners were aware of the questionnaire and chose not to participate in it or to target them 
retrospectively to investigate non-response bias. A previous questionnaire investigating 
equine management practices investigated “non-response” bias by comparing the answers of 
respondents who responded to a first mailing of a postal questionnaire to those who 
responded to a second mailing and detected minimal differences between them (Hotchkiss et 
al., 2007). In this study, it was possible to compare included respondents (those with valid 
GB post-codes) and those that were excluded (mostly from the crown dependencies and 
Ireland) to investigate selection bias. In the excluded population, more respondents kept 
horses in racing yards and livestock farms, suggesting a difference in the types of equestrian 
premises in Britain and its neighbours. 
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It is possible that the horse owners who consider answering a 30 question questionnaire about 
their horses are those with an interest in equine health and are more likely to vaccinate their 
horses. This problem is a problem also faced by postal questionnaires but must be kept in 
mind when interpreting the results.  
 
2.4.2 Over-representation of female respondents 
Females made up 95% of questionnaire respondents. This may indicate that there are more 
female horse owners in Britain or that female horse owners are more likely to participate in 
questionnaires. A recent web-based survey of cat owners had a similar gender distribution, 
with 86% of 3122 respondents being female (Habacher et al., 2010). Women are reported to 
be more interested in health related topics on the internet (Fox and Rainie, 2002) and, in a 
survey of pet-owning households in the USA, women tended to carry the primary 
responsibility for animal health-care (Wise et al., 2003). Interestingly, the male respondents 
were less likely to vaccinate their horses against tetanus but more likely to vaccinate against 
herpes virus. The increased likelihood of males vaccinating against herpes virus is likely to 
be confounded by the increased likelihood of men to be horse breeders (unreported result, OR 
2, 95% CI 1.3-3.2) and the common practice of vaccinating broodmares to prevent herpes 
virus abortion. Ideally, biologically plausible associations highlighted by univariable analyses 
as being significant (at P<0.2) would be analysed in a multivariable regression model to take 
confounding factors such as the association between gender and equestrian activity into 
account.  
 
2.4.3 Herpes virus vaccination 
Hotchkiss et al., (2007) were surprised with their finding that 20.6% of respondents to their 
questionnaire reported to vaccinate their horses against herpes virus. They expected fewer 
respondents to vaccinate against herpes as it was conventionally associated with pregnant 
mares.  In that paper, it was suggested that a lack of understanding of what a herpes virus 
vaccination was led to an erroneously high proportion of positive claims regarding this 
vaccination.  Nineteen of 46 respondents (41%) of respondents under the age of 16 claimed to 
vaccinate their horses against herpes virus compared to only 9.3% of all 3285 respondents 
who answered this question. Similarly, 15/80 (19%) of non-owners who rode or loaned 
horses claimed to vaccinate against herpesvirus. The variables of being aged under 16 and not 
owning a horse were also associated (OR 4, 95%CI 1.4-11.4).  The most likely explanation 
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for these unexpected results is, that similarly to the what Hotchkiss et al., (2007) suspected of 
their survey respondents, the younger participants in our survey may not have fully 
understood what herpesvirus vaccination was.  The association of East Anglia and point-to-
point activities with herpes vaccination could be explained by the outbreak of EHV-1 
meningoenecphalopathy in East Anglia and in several national hunt horses over the past few 
years. Amidst these recent outbreaks, there have been calls for widespread vaccination 
against herpes virus in order to increase the equine population resistance. Our results indicate 
that current herpes virus vaccination practices leave much of the British equine population 
susceptible to this disease. It appears that horses kept on larger premises, with international 
travel, importation and many activities are more likely to be vaccinated against herpes-virus. 
However, multivariable logistic regression would be ideally used to decipher which of these 
factors was primarily associated with herpesvirus vaccination and which were confounded by 
their associations with other factors. It is difficult to explain why respondents from Scotland 
and South West England have reduced odds of vaccinating their horses against herpesvirus, 
especially as respondents from South West England were more likely to breed their horses. 
This might suggest that owner and veterinary education efforts regarding herpesvirus 
vaccination should have a regional focus.  
 
2.4.4 Influenza vaccination 
There was also regional variation in the case of influenza and tetanus vaccination, with 
respondents from Wales and South West England being less likely to vaccinate against 
influenza and respondents from Scotland less likely to vaccinate against Tetanus. This again 
highlights the regions most vulnerable to disease due to lack of vaccination coverage. It 
would be useful to compare the prevalence of influenza, tetanus and herpesvirus in these 
regions.  
 
There is a marked contrast in the influenza vaccination practices between respondents who 
engage in and travel to activities with their horses and those who do not. (OR 0.3, 95% CI 
0.1-0.9, OR 0.3, 95% CI 0.2-0.4 respectively for influenza vaccination by respondents who 
activities and those who do not engage in any activities with their horse and do not travel 
away from their own premises.) This can be partially explained  by FEI regulations for 
vaccinating horses at affiliated events as well as the regulations of many national 
organisations for competitive equestrian pursuits. Despite the common practice of 
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transporting mares for breeding, respondents who described themselves as breeders or stud 
owners were also less likely to vaccinate their horses against influenza (OR 0.5, 95%CI 0.4-
0.7). Hence (subject to further multivariable analysis of this finding) the movements of 
unvaccinated horses from the population of this current study for breeding purposes may 
facilitate dispersal of influenza. As in the case of herpesvirus vaccination, there are many 
associations between variables (e.g. horse breeding, owning extra horses, being over ≥35 
years old, being an owner who doesn‟t ride.) Multivariable analyses would be necessary to 
ascertain which of the variables are truly associated with reduced likelihood of influenza 
vaccination.  
 
The reduced likelihood of donkey owners to vaccinate their animals against influenza 
(OR0.33, 95% CI 0.16-0.67) is concerning as donkeys are more susceptible to developing 
severe clinical signs and dying subsequent to influenza (as reviewed by (Thiemann and Bell, 
2001). Furthermore, there have been calls for widespread vaccination of donkeys in Britain 
subsequent to an outbreak of influenza in donkeys in the New Forest (Caerdwell et al., 2000). 
Perhaps it is erroneously thought that “equine” influenza will not affect donkeys.  
 
2.4.5 Tetanus vaccination 
Unlike the case of influenza and herpesvirus, travel away from horses‟ premises is unlikely to 
have a bearing on tetanus infection. Tetanus is most commonly occurs after an injury 
involving the skin or hoof of an unvaccinated horse (Green et al., 1994). In spite of this, 
respondents that do not transport their horses to any activity are least likely to vaccinate their 
horse against tetanus (OR 0.5, 95%CI 0.3-0.7). Furthermore, despite no biologically plausible 
connection between lack of ridden work and risk of tetanus infection, non-riders who own 
horses are also less likely to vaccinate their horses against this disease (OR 0.5, 95% CI 0.3-
0.8).  
 
2.4.6 Conclusion 
From the above findings, our preliminary investigation into demographic factors impacting 
equine vaccination suggest that it is the less active owners who do not travel, ride or compete 
with their horses that are least likely to vaccinate their horses against influenza and tetanus. In 
the case of influenza, older people with more horses, those in the breeding industry and 
donkey owners appear to be less likely vaccinate.  Respondents under 16, those that don‟t 
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transport their horses, men and non-riders appear less likely to vaccinate against tetanus. 
Dramatically fewer respondents to our questionnaire vaccinated against herpesvirus 
compared to influenza or tetanus. Regional factors influenced vaccination coverage for all 
three diseases. 
 
To conclude, a preliminary assessment of the results of this web-based questionnaire 
endorses it as a powerful tool for analysis of British equine demography.  The overall 
vaccination coverage for influenza and tetanus of 90.3% and 95.1%, respectively, paint a 
positive picture of equine vaccination practice amongst British horse owners. However, our 
analyses have highlighted possible demographic variables where, after corroboration with 
multivariable analyses, should be focussed upon to improve vaccination coverage. 
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Chapter 3: Characterisation of G proteins in myelin 
isolated from the rumpshaker mouse model of Pelizaeus-
Merzbacher disease 
 
3.1 Background 
 
3.1.1. The role of myelin in the central nervous system 
3.1.1.1. Function 
The nervous system is composed of specialised excitable cells called neurons that receive 
stimuli and transmit electrical impulses from one part of the body or nervous system to 
another. In addition, a range of supporting cells collectively referred to as neuroglia, and 
resident immune cells called microglia constitute up to 90% of the cells in the central nervous 
system. Each neuron transmits signals to other neurons or to its end target (e.g. a muscle fibre 
in the case of an efferent nerve or to other neurons in the sensory cortex in the case of an 
afferent nerve) via a synapse. Neurons have specialised extensions called axons to transmit 
stimuli from one area to another. The speed of conduction is significantly enhanced by 
specialised glial cells (oligodendrocytes in the case of the central nervous system and 
Schwann cells in the peripheral nervous system) that provide axonal insulation by spirally 
wrapping their membrane processes around axons during development to form a myelin 
membrane (Pedraza et al., 2001) (Figure 3.1). Myelination greatly increases the speed of 
impulses by promoting saltatory (“leaping”) conduction of the stimulus between the 
unmyelinated segments (the nodes of Ranvier). As well as axonal insulation, myelin is 
essential for normal axonal transport of membranous organelles and proteins (Edgar et al., 
2004b) with neurodegeneration occurring when myelin is absent or defective due to disease 
processes (Yin et al., 2006). However, not all axons are myelinated. Unmyelinated neurons 
tend to contain small diameter axons that are involved in specific functions such as pain 
reception (Julius and Basbaum, 2001). 
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Figure 3.1: Oligodendrocyte and axons. Plasma membrane extensions from one oligodendrocyte can 
spirally wrap around multiple axons and a single axon may be myelinated by multiple oligodendrocytes.  
 
 
 
3.1.1.2. Myelin components 
Myelin consists of 40% water. Of its dry weight, lipids are the most abundant component, 
making up 70%. The remaining 30% of dry weight is protein. The two most abundant myelin 
proteins are proteolipid proteins (PLP/DM20) and myelin basic protein (MBP), making up 17 
and 8% of total myelin protein respectively (Jahn et al., 2009). The remaining protein content 
consists of several classical myelin proteins as well as a large selection of proteins newly 
identified in myelin using advances in proteomic techniques (Figure 3.2). 
 
Figure 3.2: The relative abundance of myelin proteins, adapted from (Jahn et al., 2009) 
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Myelin is a highly organised laminar arrangement generated by the association of the 
extracellular and the intracellular cytoplasmic surfaces of the processes formed with each 
spiral wrap.  This generates layers defined as the intraperiod and major dense line that can be 
identified by electron microscopy.  The formation and maintenance of this highly specialised 
structure is dependent on the special and temporal orchestration of protein and lipid assembly 
into the myelin sheath (Quarles et al., 2006). (Figure 3.3) 
 
 
 
3.1.2. Pelizeus Merzbacher Disease 
The clinical symptoms of Pelizeus Merzbacher disease (PMD) were first described as early 
ataxia, nystagmus (abnormal eye movement), uncoordinated limb movement and 
developmental delay in the males of one family (Pelizaeus, 1885). Whilst mostly males were 
affected, it was the females from the family who carried the disease from one generation to 
the next indicating an X-linked genetic basis. A histopathological examination of post-
mortem nervous tissue from an affected member of the same family revealed diffuse 
hypomyelination in the central nervous system (Merzbacher, 1910). These early findings are 
consistent with what is now known about PMD; it is a genetic (recessive X linked) disorder 
associated with dysmyelenation (abnormal formation of myelin) in the central nervous 
system. The most frequent genetic abnormality is duplication of the Xq22 chromosome 
including the region encoding proteolipid protein 1 (PLP). However, deletions, triplications 
and mutations of the PLP-1 gene also cause PMD (Woodward, 2008). 
Oligo 
Axon 
External surfaces come into contact:  
Called the Intraperiod line 
 cytoplasm 
cytoplasm Cytoplasmic surface associate to 
form the Major dense line 
Figure 3.3. Schematic illustration of the formation of the myelin sheath.  The spiral wraps 
generates the intraperiod line and the major dense line sheath that can be visualised by 
electron microscopy  
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PLP and its slightly smaller isoform DM20 make up 17% of all myelin protein (Jahn et al., 
2009). Whilst Plp mutations can result in a dysmyelinating phenotype and significant 
mortality, in the study of Klugman et al. (1997) PLP null mice were not demyelinated. The 
authors of that study did notice that the intraperiod lines in the myelin remained condensed, 
suggesting reduced physical stability of the myelin and a “zipper” like function for PLP. The 
study of Rosenbluth et al. (1996) also concluded that PLP is not essential for myelination but 
is necessary for normal stability of the myelin sheath after formation. This finding 
corroborates that of (McLaughlin et al., 2006) on PLP processing in rumpshaker mice 
suggesting that it is an alteration in or an excess of PLP rather than a deficiency of PLP which 
somehow results in the dysmyelinating phenotype. Despite PLP null mice being able to form 
myelin sheaths, Edgar et al. (2004) have shown compromised axonal transport of organelles 
and proteins in axons with overlying PLP null myelin and Yin et al. (2006) reported that PLP 
in myelin is  essential for maintenance of axonal integrity. Hence, many cellular functions of 
PLP have yet to be definitively elucidated. Hypomyelination in PMD causes a spectrum of 
symptoms, from mild ataxia, tremor  and spasticity of the lower limbs (hereditary spastic 
paraplegia)  to complete loss of muscle tone, seizures and premature death (severe connatal 
PMD).  
  
3.1.3. The rumpshaker mouse model of Pelizeus Merzbacher Disease 
The spontaneous rumpshaker (Ile
186
Thr) mis-sense mutation of the Plp-1 gene in both man 
and C3H mouse generates misfolded PLP protein resulting in dysmyelination. 
Phenotypically, there are mild symptoms of PMD or spastic-paraplegia type 2 (Griffiths et 
al., 1998; Klugmann et al., 1997) Woodward, 2008). The C3H laboratory mouse type with 
the rumpshaker mutation exhibits ataxia and tremor but has normal longevity and the tremor 
diminishes as the mice age beyond 4 months. However, in aged mice beyond 1 year of age an 
axonopathy develops supporting the role of PLP in maintaining axonal integrity (Edgar et al., 
2004a). It was also observed that changing the genetic background of the rumpshaker had a 
profound effect on the phonotype. When this mutation occurs in a C57/BL6 background, 
hypomylination is more severe and mice are prone to seizures and premature death (Al-
Saktawi et al., 2003). 
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3.1.4. PLP dynamics in the rumpshaker mouse model 
The PLP content of rumpshaker myelin is markedly reduced compared to wild type and other 
myelin proteins included MBP are also reduced. It has been shown that the low steady state 
levels of PLP in the rumpshaker model are primarily the result of increased degradation 
rather than reduced synthesis (McLaughlin et al., 2006). There is a cellular unfolded protein 
stress response and sub-normal amounts of PLP are integrated into the cell oligodendrocyte 
membranes (Griffiths et al., 1998; McLaughlin et al., 2006; McLaughlin et al., 2007;Barrie et 
al., 2010).  McLaughlin et al. (2007) reported that there was no difference in the PLP 
dynamics in C3H compared to C57 rumpshakers, indicating that this did not play a role in the 
dramatic difference in the phenotypes of the rumpshaker mutation on C3H and C57 genetic 
backgrounds. The restoration of the PLP/DM20 content of rumpshaker myelin with wild-type 
Plp through genetic complementation (rumpshaker heterozygote females were crossed with 
male mice carrying a transgene that contained increased doses of the Plp-1 gene) improved 
the phenotype and myelin integrity. However, hypomyelination persisted and stress pathways 
remained activated, suggesting that the rumpshaker was associated with a toxic gain of PLP 
function as well as a loss of function (Barrie et al., 2010). Interestingly, the levels of myelin 
basic protein (MBP), which is essential for normal myelination and myelin compaction, are 
low in rumpshaker mice. MBP levels were not restored at peak myelination (P20) but did 
recover at P60 with transgenic complementation with wild-type Plp in the rumpshaker 
models in the study of (Barrie et al 2010). This suggests that it is the toxic gain of function of 
rumpshaker PLP influences the co-ordinated assembly of MBP into the myelin sheath 
although a loss of function may also affect MBP levels. It is possible that increased turnover 
of misfolded PLP (as shown by Mc Laughlin et al 2006) is overloading the organelles 
responsible for protein degradation and synthesis (as evidenced by the prominent 
endoplasmic reticula and golgi complexes described by (Griffiths et al., 1990). This may 
compromise the synthesis and transportation of other proteins such as MBP.  
 
3.1.5 Myelin Basic Protein  
MBP is the second most abundant myelin protein after PLP, making up 8% of all myelin 
protein (Jahn et al., 2009) and is required for normal myelination (Readhead et al., 1987). 
The myelin-deficient mutant shiverer mouse lacks basic protein (MBP) in the myelin of its 
central nervous system and causes sever hypomyelination MBP interaction with the 
cytoplasmic leaflets of the myelin processes is thought to cause two opposing leaflets to 
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physically associate, resulting in myelin membrane compaction (Omlin et al., 1982) and 
Readhead et al 1987. This is facilitated by the high positive charge of MBP and negative 
charge of cytoplasmic membranes (Harauz et al., 2004) Furthermore, MBP is believed to be 
involved with lipid packing and organisation in the membrane which is important for 
membrane assembly and signalling events (Fitzner et al., 2006)( MBP is significantly 
reduced in the rumpshaker mouse (Al-Saktawi et al., 2003).  
 
3.1.6. Phosphotidylinositol 4,5-Bisphosphate (PIP2)  
PIP2 is the major polyphosphoinositide in mammalian cells. It has a myriad of functions 
including being a lipid anchor in the plasma membrane and attachment of the cytoskeleton to 
the plasma membrane, interaction with many different proteins, endo and exocytosis and 
membrane trafficking of proteins. It is believed that the non-uniform distribution of PI2 in the 
lipid membrane is what enables this spectrum of functions. An important role of PIP2 is as 
the source of two second messengers in the cell; diacylglycerol (DAG) and inositol1,4,5-
trisphosphate (IP3) (McLaughlin et al, 2002). Cellular phospholipase C (PLC) and 
phosphoinositide 3-kinase (PI3-kinase) breaks PIP2 down to produce DAG and IP3(Berridge, 
1993). These second messengers stimulate a variety of protein kinases and intracellular 
calcium release. Activation of the Gαq subunits of heterotrimeric G proteins by G protein 
coupled receptor agonist binding on the plasma membrane activates PLC mediated 
breakdown of PIP2. A pilot study by Dr. Mark Mclaughlin has shown significantly decreased 
levels of PIP2 in C3H rumpshaker mice (Appendix Figure A.4).  
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Figure 3.4.  Schematic illustration of a potential signalling cascade involving PIP2 that influences MBP 
association with the myelin sheath 
 
 
 
 
 
3.1.7. Interactions between PIP2 and MBP 
A crucial interaction between PIP2 and MBP has recently been reported (Nawaz et al., 2009). 
When PIP2 was hydrolysed, it caused dissociation of MBP from the plasma membrane. 
Furthermore, when PIP2 enriched endosomal vacuoles were induced in a primary 
oligodendrocyte culture, MBP redistributed to these vacuoles. PIP2 has a negative charge 
which lends itself to MBP docking (McLaughlin et al., 2002).  The IP3 product of PIP2 
breakdown causes increased intracellular calcium release which also results in dissociation of 
MBP from the glial cell plasma membrane (Nawaz et al., 2009). The PLC PIP2 hydrolysis 
pathway also results in the activation of protein kinase C which catalyses the phosphorylation 
of MBP (Kishimoto et al., 1985).  Phosphorylated MBP is likely to have an altered 
interaction with lipids present in the myelin sheath. 
 
 
 
 
 
76 
 
3.1.8. G proteins 
Guanine nucleotide binding (G) proteins propagate incoming messages from receptors to 
effector proteins, switching from an inactive to active state by exchanging a GDP molecule 
for a GTP molecule. In a dormant state, G-proteins are composed of three subunits,  and 
. Upon activation, heterotrimeric G proteins dissociate into α and βγ subunits which migrate 
to membrane microdomains to activate their target proteins (Vögler et al., 2008). There are 
16  G protein -subunits, five  and 14  encoded on the mammalian genome (Milligan and 
Kostenis, 2006). G protein sub-types are involved in the signalling pathways for a diverse 
spectrum functions. The Gαq subunit activates PLC mediated breakdown of PIP2 and the 
DAG and IP3pathway (Gilman, 1987). Another α subunit, Gαo has been found in high 
quantities (1% of membrane protein) in bovine brains (Sternweis and Robishaw, 1984), with 
Gαo deficient transgenic mice showing multiple neurological deficits (Jiang et al., 1998). Gαo 
is known to regulate potassium and calcium ion release as well as activating adenylate 
cyclase and is integral to cellular responses to neurotransmitter-receptor binding  (Jiang and 
Bajpayee, 2009) 
 
Gβγ subunits have a plethora of targets and actions also, including potassium and calcium 
channel regulation, phospholipase C activation, adenyl cyclase and MAP kinase activation 
(Clapham and Neer, 1997) as well as more recently identified interactions with receptors 
within the Golgi apparatus and endoplasmic reticulum and modulation of the activity of Gα 
subunit activity (Dupre et al., 2009) 
 
The possible influence of Gαq and Gβγ proteins on PIP2 levels (and subsequently MBP 
function) through the PLC pathway is clear (Figure 3.4). However, it is only a recent pilot 
study that highlighted the altered PIP2 levels in rumpshaker mice (Mark McLaughlin, 
unpublished observations in appendix.) The foremost question in the wake of these findings 
with PIP2 is whether G protein levels altered in the myelin of rumpshaker mice. G proteins 
and their G protein coupled receptors have been detected in myelin (Jahn et al., 2009). 
However, to our knowledge, no previous study has measured G protein levels in the myelin 
of rumpshaker mice.  
 
The results of our study show significantly increased levels of Gαo and Gαq in the myelin of 
C3H rumpshaker mice compared to that of matched wild-type controls. Ancillary 
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investigations comparing the levels of MBP, MAG, HSP90 and ASPA indicate that this result 
is unlikely to be technical issue associated with the isolation of myelin from a 
hypomyelinated mouse. 
 
3.2. Aims and Objectives 
 
This project aims to ascertain if Gαq, which is involved in the PIP2 degradation and 
intracellular calcium release, is more abundant in mice with the rumpshaker mutation. An 
ancillary aim is to characterise the levels of Gαo, and abundant protein in central nervous 
tissue in the myelin extracted from rumpshaker and wild-type mice.  
 
Specifically, our objectives are to: 
 
1. Ascertain if Gαo, Gαq and Gβ can be detected in the myelin and other central nervous 
system fractions of rumpshaker and wild-type mice.  
2. Measure and compare Gαo, Gαq and Gβγ in rumpshaker and wild-type mice. 
3. Determine if there is any association between the G-protein levels and the extend of 
hypomyelination using mouse models with a spectrum of hypomyelination  
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3.3. Materials and methods 
 
3.3.1 Breeding and genotyping of mice (Performed by Dr Mark McLaughlin and Jennifer 
Ann Barrie). 
 
The rumpshaker Plp1 (Ile
186
Thr) mis-sense mutation occurs spontaneously on the genetic 
background of C3H/HeH crossed with 101H mice and has been maintained on a C3H/101 
hybrid background (Griffiths et al., 1990). It is now referred to as C3H . In order to impose 
this mutation on C57/BL6 genetic background (now referred to as C57), female rumpshaker 
heterozygotes on a C3H background were crossed with C57 males. The female heterozygous 
offspring were then back-crossed with wild-type C57 males 6-10 times, resulting in a 
rumpshaker mutation on a C57 background.  The backcrossing of rumpshaker onto a C57 
background was conducted to unify the genetic background of the rumpshaker with the 
transgenic mouse line #66 that harbours additional copy numbers of the wild type Plp1 gene.  
This would permit a genetic complementation study to restore the level of wild type PLP in 
the rumpshaker by crossing heterozygote female rumpshaker with male mice containing the 
Plp1 trangene. Rumpshaker mice were identified by their clinical signs and PCR genotyping 
and restriction digest, as the rumpshaker mutation contains a site for the AccI restriction 
enzyme (Schneider et al., 1992). Only affected male mice and their wild type littermates were 
used for this present study. Transgenically complemented mice were identified by PCR using 
primers based on the T7 viral promoter that is associated with the PLP transgene and the 3‟ 
flanking region of the Plp gene (Readhead et al., 1994). The mice were killed by CO2 
overdose, their brains and spinal cords were rapidly removed and snap frozen in liquid 
nitrogen until required. Spinal cord samples only were used for this particular study due to 
the greater degree of homogeneity in their cellular and myelin content. All animal studies 
were approved by the Ethical Committee of the University of Glasgow and licensed by the 
U.K. Home Office.  
 
3.3.2 Myelin extraction (Performed by Jennifer A Barrie) 
 
Myelin was extracted from spinal cords from one wild type mouse or two pooled mutant 
mice per experiment. The spinal cord tissue was added to 0.85 Molar sucrose (Sigma-
Aldrich) containing 1mM concentration of both sodium pyruvate and sodium orthovanadate 
(phosphatase inhibitors) and a protease inhibitor cocktail (Sigma-Aldrich). Following 
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homogenization and high speed centrifugation, myelin was collected from the interface of 
0.25/0.85M sucrose and subjected to 3 rounds of osmotic lysis as described by Al-Saktawi et 
al. (2003) (Figure 3.5). The solutions were kept on ice throughout the myelin extraction. The 
end products of the myelin preparation were myelin, supernatant (cytosol enriched) and pellet 
(membrane enriched) fractions. Samples of the total spinal cord homogenate were also taken. 
All samples were stored at -20
o
C until further processing. 
 
 
 
3.3.3. Protein assay 
The concentration of protein in each sample was calculated using a commercial assay kit 
(Pierce® BCA Protein Assay Kit) which is based on bicinochoninic acid (BCA) and the 
biuret reaction for the colorimetric detection and quantification of total protein. The protein 
assay was conducted according to the manufacturer‟s instructions. 
 
3.3.4. Sodium dodecyl(lauryl)sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
The separation of proteins was performed using SDS-PAGE electrophoresis.  These analyses 
were performed using precast Nu-Page gels purchased from Invitrogen.   The samples were 
prepared to a total volume of 21μl including 7μl of 3x concentration 
sodiumdodecylsulphate/dithiothreitol (SDS/DTT) denaturing buffer and heated to 90ºC for 4 
minutes, to linearise the protein and allow SDS association at a uniform charge to protein 
Figure 3.5: Schematic outlining the myelin extraction protocol 
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ratio. Ten or twelve one mm well Invitrogen 4-12% gradient gels were loaded with samples 
together with the SeeBlue® Plus2 pre-stained molecular weight standards (Invitrogen) as 
references for the molecular weight of the proteins. Electrophoresis was conducted in a MES 
SDS buffer at a constant voltage (135 Volts) for one hour.  After PAGE, the gels were either 
stained with silver stain or electro-transferred to nitrocellulose membranes for western 
blotting.  
 
3.3.5. Silver staining  
In order to gain a visual appreciation of the protein profile of each sample, the proteins were 
stained using a sensitive silver-staining protocol. This method permitted a comparison of the 
profile between the various genotypes and also provide an index of the consistency of the 
amount of protein loaded onto the gel. The Invitrogen Silverexpress® system was used 
according to manufacturer‟s instructions. Initially, for the earlier C3H samples, 2μg of each 
sample was loaded onto the PAGE gel for electrophoresis prior to silver staining. However, 
due to heavy staining of the samples, this was reduced to 1 μg of each sample for the latter 
C57 samples.  
 
3.3.6. Samples used 
As a pilot study, spinal cord fraction samples from a single representative each genotype 
were subjected to western blotting using G-protein antibodies. When it was established that 
G-proteins antibodies can react with the specific proteins in myelin, the case-control study 
commenced. Pellet fractions from 4 C3H wild-types, 4 C3H rumpshakers, 4 C57 wild-types, 
4 C57 rumpshakers and 4 C57 rumpshaker mice containing the Plp1 trangene were subjected 
to SDS-PAGE and silver staining. Myelin fractions from the same mice were loaded onto a 
separate gel and subjected to the same procedure. The C3H and C57 samples were loaded to 
separate gels. 
 
3.3.7. Western blotting  
The above samples were loaded onto polyacrylamide gels and subjected to electrophoresis. 
Electrotransfer of proteins onto nitrocellulose membranes was performed using the Invitrogen 
iBlot® Gel Transfer system. After checking for successful transfer of proteins with Ponceau-
S staining of the nitrocellulasoe membranes, non-specific binding sites were blocked with 5% 
skimmed milk, for 1 hour at room temperature. Membranes (blots) were then incubated with 
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antibodies against Gαq, Gαo, Gβγ MBP and myelin associated glycoprotein (MAG) suspended 
in 5% skimmed milk at 4 degrees overnight on an orbital shaker. (See Tables 3.1 and 3.2 for 
antibody details.)  The blots were then irrigated three times with tris buffered saline 
containing 0.05% tween 20 (T-TBS) and incubated with the appropriate horse-radish-
peroxidase (HRP) coupled secondary antibody (suspended in 5% skimmed milk) for 2 hours. 
The irrigation procedure was repeated to remove excess and secondary antibody and 
peroxidase substrate for enhanced chemiluminescence (ECL) was applied to the blots 
Thermo-Scientific). (The HRP on the bound secondary antibody catalyses the transformation 
of ECL to its sensitized form which then goes on to react with added peroxide to produce a 
product which emits light upon decay.) The blots were exposed to Amersham Hyperfilm ECL 
(GE healthcare) film for 30 second to 10 minute intervals. The intensity (signal) of the image 
made by the chemiluminescence emitted from the blots corresponded with the initial quantity 
of the protein of interest on the blot from each sample originally loaded in the gel. The 
chemiluminescent film was scanned and the pixel density of each image was quantified with 
Scion Image software (NIH).   
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Table 3.1: Details of primary antibodies used in the study. 
Samples probed 
1° 
Antibody Isotype Dilution Source 
C3H fractions, myelin, 
pellet C57 fractions, 
myelin pellet 
Gαq Rabbit 1;1000 
Gift from Prof. 
Graeme 
Milligan  
Gαo Rabbit 1;2000 
Gβγ Rabbit 1 in 750 
MBP Rabbit 
1 in 
25,000  Chemicon 
MAG Rabbit 1;5000  Chemicon 
C3H myelin and pellet 
ASPA Rabbit 1 in 2000 
 J Garbern 
(Gift) 
HSP 90 Mouse 
1 in 
10,000  Chemicon 
 
Table 3.2: Details of secondary antibodies used in the study. 
2° Antibody Dilution Source 
Anti-rabbit 
HRP 1;10,000 Sigma 
Anti-mouse 
HRP 1;5000  Sigma 
 
 
3.3.8 Analysis of quantitative results 
Statistical analysis of the protein data obtained from each group was compared by Student‟s 
T test was used where two sets of samples (C3H wild-type and rumpshaker) were being 
compared. Where three sets of samples (C57 wild-type, rumpshaker and rumpshaker 
transgene) were being compared, analysis of variance (ANOVA) and Bonferroni‟s multiple 
comparison test was used. Analysis was performed using Graphpad Prism 4 software 
(GraphPad software Inc, San Diego CA). 
 
 
 
 
83 
 
3.4 Results  
 
3.4.1 The assessment of sample quality, the level of variation between samples and the 
profile of each genotype by silver staining 
To assess the consistency of amount of protein loaded for each sample, protein profiles were 
visualised with silver staining.  Intensity of protein staining and the pattern obtained for each 
group appeared consistent, reflecting acceptable accuracy of protein assays and gel loading.  
The identity of some classical myelin proteins including PLP/DM20 and MBP could be 
suggested by their relative abundance in myelin and their migration on SDS PAGE gels. 
Many unidentified proteins appeared to be similar between the wild-type and rumpshaker for 
the C3H mice and for the C57 mice. However, two protein bands, one of between 28 and 35 
kDal (UP1) and one of under 15kDal (UP2) in size, appeared to have increased intensity of 
staining in the rumpshaker samples. One of the C57 rumpshaker samples (RSh2) appeared to 
have higher levels of PLP than expected. It is possible that this myelin came from a mis-
genotyped C57 rumpshaker transgene mouse (Figure 3.6). 
 
Figure 3.6: Polyacrylamide gels containing C3H and C57 myelin samples after electrophoresis and 
silverstaining. Proteolipid protein (PLP), DM20 and myelin basic protein (MBP) were identifiable as well 
as two unknown protein bands of between 28 and 35 kDals and less then 15 kDals (respectively) in size 
(UP1 and 2). C57 rumpshaker 2 (R2) had more intense silver staining representing PLP than would be 
expected for a rumpshaker. The silver staining in this sample is more consistent with the myelin of a 
rumpshaker transgene. W = wild-type, R = rumpshaker, T = rumpshaker transgene. 
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3.4.2 Assessment of the suitability of G-protein antibodies to conduct a Western blot 
analysis of myelin 
It was important to determine if the G-protein antibodies could react with specific proteins in 
the samples and allow semi-quantitative comparison between genotypes. Pilot studies were 
therefore performed on a representative sample from each genotype to assess the intensity 
and specificity of the immunocomplex across all the fractions that are obtained during the 
myelin extraction procedure.  15ug of the total, supernatant and pellet fraction were analysed 
and 2μg of each myelin sample was analysed due to the limited availability of myelin from 
the rumpshaker genotypes. 
 
3.4.2.1 Gαo in C3H spinal cord fractions 
A robust chemiluminescent signal corresponding with a protein sized between 38 and 49 
kDals was detected with 2µg samples of myelin and 15µg samples of the other fractions with 
Gαo anti-bodies. Gαo was enriched in the myelin of the rumpshaker but not of the wild-type 
(Figure 3.7).  
 
3.4.2.2 Gαq in C3H spinal cord fractions 
A robust chemiluminescent signal corresponding with a protein sized between 38 and 49 
kDals was detected with 2µg samples of myelin and 15µg samples of the other fractions with 
Gαq anti-bodies. There was also non-specific binding to proteins in the total, supernatant and 
pellet fractions of the wild-type and the total and pellet fractions of the rumpshaker spinal 
cord which were over 49 kDals in size. Gαq was enriched in the myelin of the rumpshaker 
(Figure 3.8). 
 
3.4.2.3 Gβγ in C3H spinal cord fractions and in equine myelin 
Western blot analysis of the various fractions with Gβγ antibody, detected a faint non 
quantifiable chemiluminescent signal. Subsequently, a trial was performed with higher 
quantities of wild-type mouse and equine myelin that was available in large amounts. A 
quantifiable chemiluminescent signal was produced using 20µg of murine myelin (data not 
shown). Due to the limited of quantities of myelin available from the specifically bred, 
control-matched mice, further studies using Gβγ antibody were abandoned for this project. 
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Figure 3.7: Western blot analysis to detect Gαo in C3H spinal cord fractions; total homogenate (T), 
supernatant (SN), pellet (P) and myelin (M) fractions of wild-type (W) and rumpshaker (R) mice. Proteins 
of between 38 and 49 kDal in size reacted with the Gαo antibody. For the myelin and other fractions, 
samples corresponding with 2µg and 15 µg of protein (respectively) were added to the polyacrylamide gel 
wells. The graph represents myelin signal values multiplied by 7.5 to make them comparable to the 
signals from the other fractions.    
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Figure 3.8: Western blot analysis to detect Gαq in C3H spinal cord fractions; total homogenate (T), 
supernatant (SN), pellet (P) and myelin (M) fractions of wild-type (W) and rumpshaker (R) mice. Proteins 
of between 38 and 49 kDal in size reacted with the Gαq antibody. There was also non-specific binding (NS) 
to proteins in the T, SN and pellet fractions of the WT and the T and P fractions of the RSh which were 
over 49 kDals in size. For the myelin and other fractions, samples corresponding with 2µg and 15 µg of 
protein (respectively) were added to the polyacrylamide gel wells. The graph represents myelin signal 
values multiplied by 7.5 to make them comparable to the signals from the other fractions.   
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3.4.3 Comparison of G-protein levels in the pellet fraction from C3H wild-type and 
rumpshaker mice. 
The pellet fractions were analysed in the first instance since these fractions are rich in the 
plasma membrane component where the majority of G-proteins are located in all cells present 
in the spinal cord. This would provide some insight into the global expression of these 
proteins in the non-myelin fraction from the different genotypes 
 
3.4.3.1 Gαo and Gαq in C3H pellet 
Gαo and Gαq quantities were higher in C3H rumpshaker pellets but not significantly so 
(Figures 3.9 and 3.10).  
 
 
Figure 3.9: Western blot analysis of Gαo in C3H wild-type (W) and rumpshaker (R) pellet indicated a 
non-significant increase in Gαo in the rumpshaker pellet samples. 
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Figure 3.10: Western blot analysis of Gαq in C3H pellet fractions wild-type (W) and rumpshaker (R) mice 
indicated a non-significant increase in nGαq in the rumpshaker pellet samples. Non-specific (NS) antibody 
binding was also evident. 
 
 
3.4.4 Comparison of G-protein levels in the myelin fraction from C3H wild-type and 
rumpshaker mice 
3.4.4.1 Gαo in C3H myelin  
There was significantly more Gαo in C3H rumpshaker myelin compared to that of the wild-
type mice (P-0.014) (Figure 3.11).  
3.4.4.2 Gαq in C3H myelin  
There was significantly more Gαq in C3H rumpshaker myelin compared to that of the wild-
type mice (P-0.019) (Figure 3.12).  
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Figure 3.11: Western blot analysis of Gαo inC3H myelin fractions showing significantly increased Gαo 
levels  C3H rumpshaker (R) myelin compared to wild-type (W) myelin. * denotes P<0.05 using Student’s 
T-test where n=4).   
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Figure 3.12: Western blot analysis of Gαq in C3H myelin fractions showing significantly increased Gαq 
levels  in C3H rumpshaker (R) myelin compared to wild-type (W) myelin. * denotes P<0.05 using 
Student’s T-test where n=4.   
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3.4.5 G proteins in C57 wild-type, rumpshaker and rumpshaker transgene 
3.4.5.1 Gαo in C57spinal cord fractions 
As with the C3H samples, subsequent to western blotting using anti-Gαo antibody, a robust 
chemiluminescent signal was detected corresponding with a protein sized between 38 and 49 
kDals in 2µg samples of myelin and 15µg samples of the other fractions. Gαo was enriched in 
the myelin of the wild type and the rumpshaker but not of the rumpshaker transgene (Figure 
3.13).  
3.4.5.2 Gαq in C57 spinal cord fractions 
A robust chemiluminescent signal corresponding with a protein sized between 38 and 49 
kDals was detected with 2µg samples of myelin and 15µg samples of the other fractions with 
Gαq anti-bodies. There was also non-specific binding to proteins in the total, and pellet 
fractions of all three genotypes which were over 49 kDals in size. Gαo was enriched in the 
myelin of all three genotypes. (Figure 3.14). 
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Figure 3.13: Western blot analysis of Gαo in C57 spinal cord fractions of wild-type (W), rumpshaker (R) 
and rumpshaker transgene (T) mice. For the myelin and other fractions, samples corresponding with 2µg 
and 15 µg of protein (respectively) were added to the polyacrylamide gel wells. The graph represents 
myelin signal values multiplied by 7.5 to make them comparable to the signals from the other fractions.    
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Figure 3.14: Western blot analysis to detect Gαq in C57 spinal cord fractions; total homogenate (T), 
supernatant (SN), pellet (P) and myelin (M) fractions of C57 wild-type (W), rumpshaker (R) and 
rumpshaker transgene (T)  mice spinal cord preparations. Proteins of between 38 and 49 kDal in size 
reacted with the Gαq antibody. There was also non-specific binding (NS) to proteins in the T, SN and 
pellet fractions of the WT and the T and P fractions of the RSh which were over 49 kDals in size. The 
graph represents myelin signal values multiplied by 7.5 to make them comparable to the signals from the 
other fractions.    
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3.4.6 Comparison of G-protein levels in the pellet fraction from C57 wild-type, rumpshaker 
and rumpshaker transgene mice 
3.4.6.1 Gαo in C57 pellet 
There were no significant differences in Gαo levels in pellet samples from C57 wild-type, 
rumpshaker and rumpshaker transgene mice. Levels were reduced in C57 rumpshaker 
transgene pellet samples (but not significantly so) compared to wild-type and rumpshaker 
pellet samples (Figure 3.15). 
3.4.6.2 Gαq in C57 pellet  
There were no significant differences in Gαq in pellet samples from C57 wild-type, 
rumpshaker and rumpshaker transgene mice.  Gαq levels were reduced in C57 rumpshaker 
transgene pellet samples (but not significantly so) compared to wild-type and rumpshaker 
pellet samples (Figure 3.16).  
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Figure 3.15: Western blot analysis of Gαo in C57 pellet fractions. There wasno significant difference in 
Gαo levels in pellet samples from C57 wild-type (W), rumpshaker (R) and rumpshaker transgene (T) mice. 
However there was a trend towards reduced Gαo levels in the rumpshaker transgene samples compared to 
the wild- type 
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Figure 3.16: Western blot analysis of Gαq in C57 pellet fractions.  There was no significant difference in 
Gαq levels in pellet samples from C57 wild-type (W), rumpshaker (R) and rumpshaker transgene (T) mice.  
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3.4.7 Comparison of G-protein levels in the myelin  fraction from C57 wild-type, 
rumpshaker and rumpshaker transgene mice 
3.4.7.1 Gαo in C57 myelin  
There were no significant differences in Gαo in myelin samples from C57 wild-type, 
rumpshaker and rumpshaker transgene mice. However there was a trend towards increased 
Gαo the rumpshaker and rumpshaker transgene myelin compared to the myelin of the wild-
type mice (Figure 3.17).  
3.4.7.2 Gαq in C57 myelin 
There were no significant differences in Gαo and Gαq levels in myelin or pellet samples from 
C57 wild-type, rumpshaker and rumpshaker transgene mice. However there was a trend 
towards increased Gαq levels in the rumpshaker and rumpshaker transgene myelin compared 
to wild-type  myelin. CV as above (Figure 3.18). 
 
Figure 3.17: Western blot analysis of Gαo in C57 ,myelin fractions. There was no significant difference 
between Gαo levels in myelin samples from C57 wild-type (W), rumpshaker (R) and rumpshaker transgene 
(T)  mice. However there was a trend towards increased  Gαo levels in the rumpshaker and rumpshaker 
transgene samples compared to the wild-type. 
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Figure 3.18: Western blot analysis of Gαq in C57 myelin fractions. There was no significant difference 
between Gαq levels in myelin samples from C57 wild-type (W), rumpshaker (R) and rumpshaker transgene 
(T, RShT) myelin. However there was a trend towards increased  Gαo levels in the RSh and RShT samples 
compared to the wild-type. 
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3.4.8 Exploring the possible impact of reduced myelin PLP in rumpshaker myelin  
In addition to assessing the G proteins, western blots containing the samples were probed for 
MBP and MAG to control for any artificial relative increase in G proteins due to reduced PLP 
in rumpshaker mice. I.e. if there is less PLP (which makes up 17% of all myelin protein in a 
wild-type animal) will there be relatively more of other myelin proteins? If this was the case, 
MBP and MAG would be increased in the rumpshaker samples.  
 
3.4.8.1 MBP in C3H and C57 myelin and pellet samples 
MBP levels were significantly reduced in the pellet fractions of the C3H rumpshaker 
(P=0.048) compared to the wild-type. Also, in the C57 pellet samples, MBP was significantly 
lower in the  rumpshaker and rumpshaker transgene compared to the pellet of the C57 wild-
type (P<0.001). (Figures 3.19-3.22). However, analysis of the myelin fraction found that 
there was no significant difference in MBP levels between C3H wild-type and rumpshaker 
animals or between the different genotypes on the C57 background. This western blot was of 
low quality despite multiple attempts to produce a high quality blot and hence limited 
statistical inference can be made from the results.  
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Figure 3.19: Western blot analysis of MBP in C3H pellet fractions. There was significantly reduced MBP 
levels in the pellet fractions of the C3H rumpshaker (R,) mice compared to the wild-type (W).  
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Figure 3.20: Western blot analysis of MBP in C57 pellet fractions. There were significantly lower MBP 
levels in pellet of the rumpshaker (R,) and rumpshaker transgene (T,)  compared to the pellet of the C57 
wild-type (W). There is an artefact in the gel (b) adjacent to the final T sample. 
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Figure 3.21: Western blot of MBP in C3H myelin fractions. There was no significant difference in MBP 
levels between C3H wild-type (W, WT) and rumpshaker (R, RSh)  myelin. This western blot was of low 
quality despite multiple attempts to produce a high quality blot and hence limited statistical inference can 
be made from the results.  
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Figure 3.22: Western blot analysis of MBP in C3H myelin fractions. There was no significant 
difference in MBP levels in C57 wild-type (W), rumpshaker (R) and rumpshaker 
transgene (T). The high MBP levels in rumpshaker 2 (R2, red circle on graph) are 
noteworthy as this is the mouse that we suspect to be mis-genotyped. 
 
 
 
 
 
 
 
 
 
 W                      R                      T 
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3.4.8.2 MAG in C3H and C57 myelin samples 
 
MAG was significantly reduced in the myelin of the  C3H rumpshaker group compared to the 
myelin of the  C3H wild-type group (P=0.0049).  There were no significant differences in the 
levels of MAG in the myelin of any of the C57 groups. However there was a trend towards 
MAG being lower in the myelin of the rumpshaker and rumpshaker transgene mice (Figures 
3.23 and 3.24).  
  
Figure 3.23: Western blot analysis of myelin associated glycoprotein (MAG) in C3H myelin fractions. 
There was significantly reduced MAG in C3H rumpshaker (R) myelin compared to wild-type (W). and 
P<0.05 
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3.4.9 Investigating the possibility of increased myelin contamination by non-myelin 
proteins in the rumpshaker samples.   
As dysmyelenation occurs in rumpshaker mice, their central nervous tissue contains less 
myelin than that of wild-type mice. During myelin extraction, we questioned whether the 
lower volume of rumpshaker myelin would have a relatively greater proportion of 
contamination proteins from other fractions if this were to occur. As the pellet (membrane 
enriched) fraction may represent the source with the highest density of potential 
contamination of membrane proteins and may therefore influence the G-protein content of 
myelin, we explored ratio of two proteins that are present in this fraction but are not 
associated with G-proteins. Two proteins that are enriched in the pellet were chosen to 
measure in C3H rumpshaker and wild-type myelin; heat shock protein 90 (HSP90) which and 
aspartoacyclase (ASPA)).HSP90 is a molecular chaperone and present in the nuclear and 
Figure 3.24: Western blot analysis of myelin associated glycoprotein (MAG) in C57 myelin fractions 
There was no significant difference in MAG levels in C57 wild-type (W), rumpshaker (R) and rumpshaker 
transgene (T). 
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cytosolic fractions. ASPA is a membrane-associated enzyme which hydrolyses N-
acetylaspartate and is important for normal white matter. Although ASPA has been reported 
to be present  in myelin. (Wang et al., 2007)(Wang et al., 2007), it is enriched in pellet 
fractions.  For the measurement of HSP90 and ASPA, the gels were loaded with 5µg and 2.5 
µg samples of pellet and myelin (respectively). If myelin contamination had occurred to a 
greater degree in the rumpshaker mice, we would expect an increased myelin:pellet ratio of 
HSP90 and ASPA in the rumpshaker samples compared to the wild-type.  
 
3.4.9.1 HSP and ASPA myelin;pellet ratio in C3H samples  
There was no significant difference in the myelin;pellet ratio of either HSP90 or ASPA in 
C3H rumpshaker mice compared wild-type. There was a trend for the ratio to be slightly 
higher in the rumpshakers but this was not statistically significant (Figures 3.25 and 3.26). 
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Figure 3.25: Western blot analysis of heat-shock protein 90 (HAP90) in C3H myelin and pellet fractions. 
There was no significant difference in myelin(M);pellet(P) ratio of HSP90 in C3H wild-type(W) and 
rumpshaker (R) myelin. 
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Figure 3.26: Western blot analysis of aspartocyclase (ASPA) in C3H myelin and pellet fractions. Western 
blot analysis showing no significant difference in the  myelin(M);pellet(P) ratio of ASPA in C3H wild-type 
(W) and rumpshaker (R) myelin 
   
 
Results in appendix: 
 
Please see the appendix for western blots showing PLP and phosphoralyated MBP in C3H 
wild type and rumpshaker myelin and pellet fractions. Limited statistical inference could be 
made from these blots due to non-specific anti-body binding.  
 
 
 
 
 
 
 
 
 
 
  W  W 
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3.5 Discussion 
 
3.5.1 Increased G proteins in C3H rumpshaker myelin 
Our results show significantly increased levels of Gαo and Gαq in the myelin of C3H 
rumpshaker mice compared to that of matched wild-type controls. Ancillary investigations 
comparing the levels of MBP, MAG, HSP90 and ASPA indicate that is result is unlikely to 
be a methodological artefact associated with the extraction of the myelin from 
hypomyelinated rumpshaker compared to wildtype. These findings represent the first 
investigation into G proteins in rumpshaker myelin and provide a possible link in the chain of 
events between the Plp mutation and dysmyelination.  
 
3.5.2 Link between Plp-1 mutation and rumpshaker phenotype 
There have been detailed studies on pathological changes in the central nervous tissue of  
rumpshaker mice (Edgar et al., 2004a; Griffiths et al 1998;1990), the biochemical 
characteristics of PLP metabolism in these mice (McLaughlin 2006 and 2007) and the effect 
of PLP deficient myelin on the adjacent axon (Edgar et al 2004). It is also recognised that 
lack of PLP alone will not result in the rumpshaker phenotype (Klugman et al., 1997) , that 
MBP , unlike PLP, is absolutely essential for normal myelination (Readhead et al., 1987) and 
that MBP is reduced in rumpshaker mice (Al-saktawi et al., 2003). However, exactly how 
misfolded PLP results in hypomyelenation has eluded researchers to date (Woodward 2008). 
Our findings in this current study may provide the link between the missense Plp-1 gene that 
is the known cause of hereditary spastic paraplegia, altered MBP function and subsequent 
dysmyelenation. The genetic background (C3H versus C57) upon which the rumpshaker 
mutation occurs has such a large impact on the phenotype of the mice (Al-saktawi et al., 
2003; McLaughlin et al., 2007). Hence a clear understanding this pathway from the Plp-1 
mutation to the end disease is vital for rational navigation of research and therapeutic efforts. 
 
3.5.3 Connection between increased Gαq levels and reduced PIP2 
To the author‟s knowledge, this is the first study that has measured G proteins in the myelin 
of mice with the rumpshaker mutation. The significant increase in Gαq levels in the C3H 
rumpshaker mice is confluent with the hypothesis that increased Gαq protein levels may be 
causing reduced PIP2 that was found in the pilot study or Dr McLaughlin (appendix). The 
work of Nawas et al (2009) highlighted the close electrostatic association between MBP and 
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PIP2, with dramatic reduction of MBP levels in the plasma membrane upon hydrolysis 
(artificially and by PLC) of membrane PIP2 and elevation of intracellular Ca
2+
. Subsequent to 
their findings that elevated intracellular Ca2+ disrupts the membrane association of MBP, 
Nawas et al (2009) hypothesized that Ca2+  regulates the association of MBP with the 
plasma membrane in a Calmodulin dependent manner as has been observed with other basic 
unstructured proteins.  Furthermore, the activation of protein kinase C via the PIP2 hydrolysis 
pathway is known result to in the phosphorylation of MBP (Vartanian et al., 1986) which 
may alter MBP properties and function.   
 
3.5.4 Possible effects of increased Gαo 
In contrast to our findings with Gαq, the significant increase in Gαo in the C3H rumpshaker 
myelin cannot be so readily hypothesised to be a causative factor for reduced PIP2 levels. Gαo 
is known to inhibit intracellular calcium release through breaking down DAG and also to 
prevent calcium influx into the cell. Furthermore it will reduce phosphorylation of proteins by 
inhibiting adenylate cyclise production (Jiang and Bajpayee 2009).Hence, any possible 
effects that Gαo might have on PIP2 are the opposite to those of Gαo. Whilst Gαo is abundant 
in the central nervous system with essential functions relating to ion flux in neurons (Jiang et 
al., 1998), its function in myelin is unclear. Gαo is proposed by several studies to have a role 
neuron apoptosis in Alzheimer‟s disease (reviewed by Jiang and Bajpayee 2009).  Perhaps 
there is also a apoptotic role for Gαo in the oligodendrocytes of rumpshaker mice. Apoptosis, 
contrary to the early report of (Griffiths et al., 1990), is now known to be a feature of 
rumpshaker central nervous tissue (Al-Saktawi et al., 2003). Gαo is sensitive to inhibition by 
pertussis toxin (Katada et al., 1982).  Pertussis toxin inhibition of Gαo function (in primary 
oligodendrocyte cultures) may help clarify its role in myelin.  
 
3.5.5 Reduced MAG levels in rumpshaker myelin 
(Al-Saktawi et al (2003) reported levels of MAG in the myelin of C3H rumpshaker mouse to 
be 71% of that of C3H wild-type myelin. In the same study, myelin levels of MAG in C57 
rumpshaker mice were 32% of wild-type levels.  Reduced levels of MAG in rumpshakers 
were also recorded in this current study. These reduced levels are consistent with the ideas of 
Griffiths et al. (1990),  McLaughlin et al. (2006) and  Barrie et al. (2010), suggesting that 
misfolded PLP may overload the endoplasmic reticulum and Golgi complex and interfere 
with synthesis of other proteins such as MAG. MAG normally resides in the myelin 
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membrane and it is known to be associated with maturation and maintenance of axons 
(Quarles , 2009).  The objective of our measurement of MAG was to explore the possible 
impact of reduced myelin PLP in rumpshaker myelin on the relative quantities of other 
myelin proteins. This measurement of reduced MAG in C3H rumpshakers in this study could 
be interpreted to suggest that reduced PLP in the rumpshaker was not causing relative 
increases in the proportions of other proteins subsequently relatively rather than absolutely 
elevated G proteins. Similarly, the equality of myelin;pellet ratios of HSP90 and ASPA 
(typically enriched in pellet fractions) suggests that any myelin contamination during 
preparation, whilst present at a low level, was equal in rumpshaker and wild-type samples. 
Together these findings support the contention that Gαq and Gαo are elevated in the myelin of 
C3H rumpshaker mice and are not an artifact arising from the alterations in the stiochiometric 
composition of proteins in myelin.  
 
3.5.6 Hypothesis relating altered PLP to elevated G proteins and compromise of the myelin 
membrane 
From these early findings of G protein elevations in myelin, the reasons for their elevation in 
the myelin of rumpshakers can only be hypothesised. One possibility is, that misfolded PLP 
is being inappropriately integrated into the myelin membrane and that processing the 
misfolded PLP is overloading the endoplasmic reticulum and golgi complex (consistent with 
the swollen golgi and endoplasmic reticulm described in rumpshakers by (Griffiths et al., 
1990) and altered dynamics of PLP turnover (McLaughlin et al., 2006). This would alter lipid 
synthesis and increase myelin membrane turnover. Increased lipid turnover in the membrane 
would make it more likely to have non-lamellar areas which are known to attract G proteins 
including Gαq (Vögler et al., 2008). This mechanism would result in a “vicious circle”. I.e. 
the integration of misfolded PLP into the myelin membrane is altered and the endoplasmic 
reticulum and Golgi systems are overloaded processing this misfolded PLP (mclaughlin 
2007). This will increase membrane turnover, creating more active, non-lamellar areas in the 
membrane which attract G proteins. If Gαq is activated, this will cause increased PIP2 
hydrolysis and subsequently further membrane breakdown and attraction of more G proteins, 
thus creating a cycle of  membrane breakdown that is now independent of the misfolded PLP 
which instigated it (Figure 3.28). 
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Our findings with the C57 rumpshakers were not conclusive. In the case of the pellet 
fractions, there was a trend for both Gαq and Gαo to be lower in the rumpshaker and rumpshaker 
transgene than in the wild-type. In the myelin fractions both of these proteins showed a trend 
towards elevation in the same genotypes.  This contrasts to the trends towards increased in 
pellet Gαq and Gαo in the C3H rumpshaker and significant increases in myelin in Gαq and Gαo. 
Pending further studies showing that this contrast in G protein behaviours in the different 
genetic backgrounds is significant, it could be postulated that G protein activity is somehow 
associated with ameliorating the severity of phenotype associated with the rumpshaker 
mutation.  For example, accelerated hydrolysis of PIP2 may be important for co-ordinating 
MBP association with the myelin membrane. Until further G protein measurements and  PIP2 
analysis is conducted in the myelin of C57rumpshakers, this will remain a purely speculative 
argument. 
 
Our findings and hypotheses relating to G proteins could be exciting for two reasons. Firstly, 
they may allow us to better understand the pathway from Plp-1 mutation. Secondly, G-
protein coupled receptors lend themselves to therapeutic targeting, already being successfully 
targeted with many drugs, for example beta blockers (Milligan and  Kostenis, 2006). 
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Figure 3.28 : Hypothesized connection between mis-folded PLP, increased Gαq, PIP2 breakdown and  
compromised myelin membrane.  
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3.5.7 Further work and limitations of the current study 
An initial step towards validating the above hypothesis would be to ascertain if the 
rumpshaker myelin contains more G protein because the oligodendrocyte is synthesising 
more or is it because more G protein is being attracted from the cell body to the myelin 
membrane. This could be addressed by performing primary cultures with rumpshaker and 
wild-type oligodendrocytes. Fluorescent anti-body studies could localise G-proteins and 
Western blotting could quantify the G proteins in both cultures.  Another question is whether 
the G proteins that we are quantifying are in their active state. There are now commercial 
antibodies available for epitopes specific to activated G-proteins with which we could answer 
this question through further western blotting studies.  
 
Whilst G protein levels in the C57 rumpshaker myelin showed a trend towards being 
reduced, our findings were not statistically significant. We suspect that one of the mice that 
we classified as “rumpshaker” (“rumpshaker 2”) may in fact have been a mis-genotyped 
rumpshaker transgene, as the protein profile (particularly PLP) upon silverstaining of myelin 
from this mouse was more typical of a transgene. This possible misclassification may have 
confounded our low sample numbers. Little can be concluded from the trends for G protein 
changes in the myelin of the transgenic mice. Perhaps that the study should be extended to 
include more samples given the relatively high variation encountered in these experiments. 
 
We hesitated to read too much significance into our C3H myelin MBP blots and our PLP 
blots due to heterogeneous quality of chemiluminescence and strong background 
luminescence on these blots. However changes in MBP and PLP in rumpshaker mice are well 
reported by previous authors (Barrie et al., 2010; McLaughlin et al., 2006). 
 
The two unidentified protein bands of that were identified in the rumpshaker myelin samples 
upon silver staining were smaller in size than either Gαo or Gαq (both over 40kDal in size), 
eliminating the possibility that these were confounding our Western blot results by non-
specific anti-body binding. It would be intriguing to identify these proteins that appear 
enriched upon silver staining in the rumpshaker myelin and a highly valid avenue for a mass 
spectrometric protein identification study.  
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In conclusion, this nascent study has identified significant increases in both Gαq and Gαo in 
the myelin of C3H rumpshaker mice. This, together with previous findings regarding G-
protein membrane interactions, reduced PIP2 in rumpshaker myelin, MBP interactions with 
PIP2 and the essential role of MBP in myelination may facilitate the understanding of the 
pathway between PLP mutations and the spectrum of dysmyelination as well as adding to the 
understanding of other myelin-related diseases.  
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Chapter 4: General Conclusions 
A broad spectrum of topics and techniques in molecular biology, epidemiology and cell 
biochemistry are documented in this thesis. Each of the projects is providing data to 
contribute to larger ongoing projects in the laboratories from where they originated. 
 
In the first project, our findings confirmed that lin-41 is present in H. contortus and that the 3′ 
UTR of this gene has potential let-7 binding sites. The laboratory is now creating a bacterial 
plasmid construct using the H. contortus 3′ UTR sequence and a gene encoding green 
floursecent protein. If a transgenic C. elegans can be successfully created with this construct, 
let-7 and H. contortus lin-41 3′ UTR interaction may be tested. This could then be used as a 
model with which to test methods for parasitic microRNA disruption. Validating such 
approaches in a trans-genic model would facilitate and expedite selection of the most viable 
microRNA disruption approach for testing in H. contortus itself, making most efficient use of 
resources and minimising the use of experimental sheep. 
 
The second project endorses a web-based questionnaire as a powerful tool for analysis of 
British equine demography.  Several demographic variables were highlighted where, after 
corroboration with multivariable analyses, should be focussed upon to improve vaccination 
coverage. The questionnaire is currently ongoing and will yield much valuable demographic 
information, providing more robust epidemiological artillery in the face of emerging and 
endemic equine infectious diseases. 
 
Investigation of a fundamental concept; whether guanine nucleotide binding (G) proteins are 
altered in the rumpshaker model of Pelizeus Merzbacher Disease, was the focus of the third 
study. The identification of significant increases in Gαq and Gαo in the myelin of C3H 
rumpshaker mice has generated hypotheses about the pathway connecting the Plp-1 mutation 
to the rumpshaker phenotype. It may also provide an answer for the important question of 
why the same mutation results in dramatically different phenotypes when imposed upon 
different genetic backgrounds. Altered G protein levels and previous findings regarding G-
protein membrane interactions, reduced PIP2 in rumpshaker myelin, MBP interactions with 
PIP2 and the essential role of MBP in myelination may facilitate the understanding of the 
pathway between PLP mutations and the spectrum of dysmyelination.  This may also add to 
the understanding of other myelin-related diseases.  
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Together, these projects have provided an invaluable opportunity to gain skills in a spectrum 
of scientific techniques. Whilst in diverse areas, each project addressed a disease challenge 
through a novel approach. There are increasing collaborations between scientists with 
different specialisms, as no one approach can address all aspects of a problem. There is a 
symbiotic relationship between epidemiology and the fundamental sciences. Hypotheses 
about disease can be generated through analysing field observations or questionnaires, as in 
project 2. These hypotheses can be explored in depth through the complementary techniques 
of molecular and cell biology, as in projects 1 and 3. Statistical techniques can then be used 
to make sense of laboratory findings and to put them in context. Finally epidemiological 
studies can be used to assess the effect of interventions arising from fundamental and 
translational research in the population. Hence this thesis represents a snapshot of novel ways 
to solve problems in 3 mutually complementary sciences.  
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Appendix  
 
Project 1:  
 
Figure A.1 Portion of H. contortus supercontig 0048734 which aligned with these sequences of Hc-lin-41 
3′ untranslated region fragments amplified through 3′ rapid amplification of cDNA ends. The aligned 
portions are highlighted in yellow. It was this sequence that was searched for potential let-7 binding sites.  
CGTTTGGCCGTGCTGTCCTCTCGTGACACACCAGAAATGAAAGTATATGG 
TACGGAGGGAAGTGTCGAGGGGATGTTCTGCCGCCCACAAGGAGTGAAGG 
TTGATCCAGAGGGTCATATTCTTATTTGTGATTCTCGGAACAATCGCGTT 
CAGGTTAGTTCTTTCATGCTTGTTCATCTGCTGTCTTTCTTAAACTGGTC 
TGTCTGCAGGTATTTTCTGGAGATGACATGCGGTGCATCGCCGTCTTCGG 
ACAATCATCCTCGTCTGGTGGTTTCGAGATGCCTGCTGAGCTACCTGCGC 
CGTTCCGCTCTGTCGGGCCCACTCCCTTCCATGCCTCCACCACTCCTGCG 
AGTGGCGTCGCTCTTGAAACCCCTACAGGTGGGCCTCGTCCATTGCTGGA 
CCGCCCAACTGATGTGGCAATTGCCCCAGACGGTCGAATCTATGTGGTTG  
TCGCTTCGCCTTCTAGCAACAGCTATTATGTTGCTGTTGTTCATCTCAAG 
TGGAAATCTGGCTTCAAGCCAACATTTGTTTTGTGCTGTATCGCTAGGTG 
AACATGTGCTATTTGTGCTTTGAGCCGCTGCGAGTCTCGCGTTCCCTTCA 
GGCCTGCCTGCTCTTGTCATTTCCACATGTGATTCGATACGCTTCTTTTA 
TTTCTCGTTGTTTGATTTGTTTCAAAGATTCACACAGAGTTTATTGTTCT 
TCTCTCCACCGTAGTAACCACAGTCTCGTCCCCCTCCCTGCCCCATCCAC 
ATATATTGCTCATATCACCTGGGCTTATCGCTCTTGTACACGATTCGCAT 
GGTCTACCCAAGAGGTTCTGCTGGAGCTGTCTTTTCAAAACCTTTAATCT 
CTCGCTCTCTCTCACACACGCTCTCTGTCCATGTTAATGTAACTGCTTCT 
ACCTCCACCCTCGCATTCTAGCCGCTGACTAGCTGTTTCTTGTTACGGCG 
ATCTACCTGCATACAACCGTCTTTACCTCAAACCATGCGAAACCTCGTCT 
AATCCAGCCTCATCTCAGTTTTCGCATTCGAGACCTCCTTCGAGCATGTT 
TTAGTCTATTAGCTAAAAACGCCTCATTTCCTTCAGCTCAGCGTACCCTA 
CCGTTCTGTGAAAAGAAGGATTCCGGAACCGATGGGGAGATTCAGTCGTT 
CGCTTATATTCCTTAGCTTTTGCCATGTCACTGTTTTAGTACCATCTTCG 
TGTTCCGCGCCGCGGTTTTGTACAGTAGATTGCGAGGCCTCGCCCATTGT 
CTTCAAGTCTAACTAGGGCCCCAATGCCCTTAACTGTGTGTCTCTATGTG 
TGTGCACCTGCATTGTCTCGAATGCTCTCGAGGTAGACGATCGCCGTTTT 
GATTTGTTTTAGTTACTTCCTTTCATGGATATCCAATTTCGCTTCTGACC 
GCAGATTTCGTGATAGCGGTGTACATTGTTTTAACCGTTTTTATTACTGC 
AGGGTATCGTTATGAGAGCCCAGTGAAAAGGAATACCAGTGAATATCCCG 
GTTCGAATTGAATGTGTTTGAGAAAAGTTGAGCTATTTATTAGAGAGTAT 
GTTTGTAAGCTAATCCTGGTGTTCAATGTTACGTTTTATCGCTTGTATTA 
AAGTTCGTTTTGTTTTT 
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Appendix for project 2  
 
Table A.1: Description of the proportions of horses vaccinated and unvaccinated against any of influenza, tetanus or herpes associated with demographic variables, 
including univariable odds ratios and likelihood ratio test P values of association with influenza vaccination. Blue and yellow highlighting denote decreased and 
increased odds (respectively)  of a variable being associated with vaccination. 
Variable 
Total Respondents (n=  3285 who 
answered vaccination questions) Unvaccinated           
(%) 
Vaccinated              
(%) 
Coefficient 
Standard error 
of coefficient 
Wald P 
value 
Likelihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
Type of premises                   
 Arable farm 173 4 (2.2) 178 (97.8) 0.90 0.26 0.368 0.335 1.59 0.58-4.36 
 Livery yard 991 18 (1.7) 1022 (98.3) -0.43 0.25 0.001 <0.001 2.45 1.47-4.09 
 Livestock farm 405 20 (4.8) 396 (95.2) 0.46 0.52 0.087 0.101 0.65 0.4-1.06 
 Other premises 167 6 (3.5) 164 (96.5) -0.08 0.47 0.911 0.912 0.95 0.41-2.2 
 Own premises 1025 39 (3.6) 1033 (96.4) 20.06 19620.70 0.523 0.57 0.88 0.59-1.31 
 Private yard 674 23 (3.3) 673 (96.7) -0.13 0.20 0.903 0.902 1.03 0.65-1.64 
 Racing yard 16 0 (0) 14 (100) -0.63 0.26 0.999 0.968 ∞ 0-∞ 
 Rented pasture only 293 18 (5.7) 297 (94.3)  0.03 0.24 0.018 0.026 0.53 0.32-0.9 
 Riding school 149 5 (3.62) 133 (96.4) -0.05 0.43 0.871 0.873 0.93 0.37-2.31 
Region                   
Midlands 372 8 (2.2) 364 (97.8)         REF 1   
East Anglia 427 15 (3.5) 412 (96.5) -0.50 0.44 0.255 0.246 0.6 0.25-1.44 
London 11 1 (9.1) 10 (90.9) -1.52 1.11 0.171 0.247 0.22 0.03-1.93 
North East England 367 10 (2.7)  357 (97.3) -0.24 0.48 0.613 0.612 0.78 0.31-2.01 
North West England 371 13 (3.5) 358 (96.5) -0.50 0.46 0.27 0.263 0.61 0.25-1.48 
Scotland 347 15 (4.3) 332 (95.7) -0.72 0.44 0.105 0.096 0.49 0.2-1.16 
South Central England 385 10 (2.6) 375 (97.4) -0.19 0.48 0.687 0.686 0.82 0.32-2.11 
South East England 304 8 (2.6) 296 (97.4) -0.21 0.51 0.683 0.683 0.81 0.3-2.19 
South West England 527 21 (4) 506 (96) -0.64 0.42 0.131 0.117 0.53 0.23-1.21 
Wales 174 10 (5.7) 164 (94.3) -1.02 0.48 0.035 0.035 0.36 0.14-0.93 
Activities                   
Participates in at least 1 activity 3265 110(3.4) 3155(96.6)         REF 1    
No activities 20 1(5) 19(95) -0.41 1.03 0.69 0.82 0.66 0.09-4.99 
Travels to activities 2860 77(2.7) 2783(97.3) 
  
    REF 1    
Does not travel 425 34(8) 391(92) -1.15 0.21 0.00 0.00 0.32 0.21-0.48 
Affilliated competitions 999 12 (1) 987 (99) 1.31 0.31 <0.001 <0.001 3.72 2.04-6.81 
Unaffilliated competitions 1870 25 (1) 1845 (99) 1.56 0.23 <0.001 <0.001 4.78 3.04-7.5 
Hacking 3069 88 (3) 2981 (97) 1.40 0.25 <0.001 <0.001 4.04 2.49-6.53 
Hunting 756 18 (2) 738 (98) 0.45 0.26 0.086 0.072 1.57 0.94-2.61 
Breeding 569 17 (3) 552 (97) 0.15 0.27 0.57 0.564 1.16 0.69-1.97 
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Variable 
Total Respondents (n=  3285 who 
answered vaccination questions) 
Unvaccinated           
(%) 
Vaccinated              
(%) 
  
Wald P 
value 
Likelihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
Dressage 1699 18 (1) 1681 (99) 1.76 0.26 <0.001 <0.001 5.82 3.5-9.68 
Trailblazers 359 4 (1) 355 (99) 1.21 0.51 0.018 0.004 3.37 1.23-9.2 
Show jumping 1314 22 (2) 1292 (98) 1.02 0.24 <0.001 <0.001 2.78 1.73-4.45 
Eventing 728 10 (1) 718 (99) 1.08 0.33 0.001 <0.001 2.95 1.53-5.68 
Endurance 604 9 (1) 595 (99) 0.96 0.35 0.006 0.002 2.61 1.31-5.2 
Driving 239 8 (3) 231 (97) 0.01 0.37 0.978 0.977 1.01 0.49-2.1 
Western 156 6 (4) 150 (96) -0.14 0.43 0.741 0.746 0.87 0.38-2.01 
Showing 1326 26 (2) 1300 (98) 0.82 0.23 <0.001 <0.001 2.27 1.45-3.54 
vaulting 44 0 (0) 44 (100) 20.07 11067.60 0.999 0.081 ∞ 0-∞ 
Point-to-point 97 2 (2) 95 (98) 0.52 0.72 0.471 0.434 1.68 0.41-6.91 
Riding club.pony club 1318 14 (1) 1304 (99) 1.58 0.29 <0.001 <0.001 4.83 2.75-8.5 
Lessons 2134 38 (2) 2096 (98) 1.32 0.20 <0.001 <0.001 3.74 2.51-5.57 
Farrrier 2992 94 (3) 2898 (97) 0.64 0.27 0.018 0.027 1.9 1.12-3.23 
Facilities 1785 22 (1) 1763 (99) 1.62 0.24 <0.001 <0.001 5.05 3.15-8.1 
lessons 1835 30 (2) 1805 (98) 1.27 0.22 <0.001 <0.001 3.56 2.33-5.44 
Other activities   10 (2) 486 (98) 0.60 0.34 0.072 0.052 1.83 0.95-3.52 
Respondents' type of equestrian involvement                   
Owner that rides 2940 82 (2.8) 2858 (97.2) 1.16 0.22 <0.001 <0.001 3.2 2.06-4.96 
Owner non rider 220 18 (8.2) 202 (91.8) -1.05 0.27 <0.001 <0.001 0.35 0.21-0.59 
Non-owner that loans/rides 80 9 (11.3) 71 (88.8) -1.35 0.37 <0.001 0.002 0.26 0.13-0.53 
Professional 298 4 (1.3) 294 (98.7) 1.00 0.51 0.05 0.022 2.73 1-7.46 
Livery yard proprietor 103 5 (4.9) 98 (95.1) -0.39 0.47 0.403 0.428 0.68 0.27-1.69 
Thoroughbred industry employee 25 0 25 (100) 20.06 14682.80 0.999 nc ∞ 0-∞ 
Breeder 269 13 (4.8) 256 (95.2) -0.41 0.30 0.171 0.192 0.66 0.37-1.2 
Donkey owner 41 3 (7.3) 38 (92.7) -0.83 0.61 0.172 0.221 0.44 0.13-1.44 
Member travelling community 3 0 3 (100) 20.06 42385.60 1 nc ∞ 0-∞ 
Other 490 17 (3.5) 473 (96.5) 0.12 0.46 0.799 0.796 1.13 0.45-2.8 
Area next to premises                   
Woodland 1283 31 (2.4) 1252 (97.6) 0.52 0.21 0.016 0.012 1.68 1.1-2.56 
Grazing 2770 91 (3.3) 2679 (96.7) 0.17 0.25 0.491 0.498 1.19 0.73-1.95 
Hay 1145 37 (3.2) 1108 (96.8) 0.07 0.20 0.732 0.731 1.07 0.72-1.6 
Urban 177 7 (4) 170 (96) -0.17 0.40 0.663 0.671 0.84 0.39-1.84 
Semirural 728 21 (2.9) 707 (97.1) 0.21 0.25 0.404 0.394 1.23 0.76-1.99 
Industrial 69 2 (2.9) 67 (97.1) 0.16 0.72 0.824 0.819 1.18 0.28-4.86 
Running water 765 22 (2.9) 743 (97.1) 0.21 0.24 0.38 0.371 1.24 0.77-1.99 
Standing water 383 11 (2.9) 372 (97.1) 0.19 0.32 0.56 0.55 1.21 0.64-2.27 
Coastal 73 6 (8.2) 67 (91.8) -0.97 0.44 0.026 0.048 0.38 0.16-0.89 
Other 490 17 (3.5) 473 (96.5) -0.03 0.27 0.904 0.905 0.97 0.57-1.64 
International travel                   
No international travel 3165 110 (3.5) 3055 (96.5)         REF 1   
International travel 120 1 (0.8) 119 (99.2) 1.46 1.01 0.149 0.062 4.28 0.59 - 30.95 
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Variable 
Total Respondents (n=  3285 who 
answered vaccination questions) 
Unvaccinated           
(%) 
Vaccinated              
(%) 
  
Wald P 
value 
Likelihood 
ratio P 
value 
Odds 
ratio 
Odds ratio 95% 
confidence 
intervals 
Imports                   
Respondent doesn't import 2998 105 (3.5) 2893 (96.5)         REF 1   
Respondent imports 112 2 (1.8) 110 (98.2) 0.69 0.72 0.337 0.284 2 0.49-8.19 
Respondent age-group       
-0.09 0.36 
        
45 to 54 years old 919 25 (2.7) 894 (97.3) -0.13 0.32   0.183 REF 1   
16 to 24 years old 404 12 (3) 392 (97) -0.25 0.29 0.8 0.621 0.91 0.45-1.84 
25 to 34 years old 519 16 (3.1) 503 (96.9) -0.51 0.28 0.692 0.681 0.88 0.46-1.66 
35 to 44 years old 721 25 (3.5) 696 (96.5) -0.91 0.63 0.384 0.882 0.78 0.44-1.37 
55 years or older 673 30 (4.5) 643 (95.5)     0.063 0.183 0.6 0.35-1.03 
Under 16 years old 46 3 (6.5) 43 (93.5)     0.147 0.29 0.4 0.12-1.38 
Respondent gender       -0.71 0.34         
Female 3127 101 (3.2) 3026 (96.8)         REF 1   
Male 158 10 (6.3) 148 (93.7) -0.01 0.01 0.039 0.056 0.49 0.25-0.97 
Horses owned                   
Odds change per  extra horse owned           0.337 0.383 0.99 0.97-1.01 
        0.02 0.01         
Horses on premises                   
Odds change per extra horse on premises           0.039 0.021 1.02 1-1.04 
        -0.01 0.01         
Maximum number of hours travelled       0.20 0.10         
Odds change per extra hour travelled to horse care       0.23 0.05 0.157 0.216 0.99 0.97-1.01 
Odds change per extra hour travelled to local events       
  
0.057 0.008 1.22 0.99-1.49 
Odds change per extra hour travelled to national 
events 
          <0.001 <0.001 1.26 1.14-1.4 
    0.90 0.26     
    -0.43 0.25     
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Figure A.2: The variables which were associated with reduced odds of any vaccination (with 95% 
confidence intervals less than 1). The arrows between variables represent associations between them (the 
presence of one variable increasing the odds of the presence of the other with an odds ratio with 95% 
confidence intervals greater than 1 
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Figure A.3: The variables which were associated with increased odds of any vaccination (with 95% 
confidence intervals greater than 1). The arrows between variables represent associations between them 
(the presence of one variable increasing the odds of the presence of the other with an odds ratio with 95% 
confidence intervals greater than 1). The activities highlighted in yellow are those associated with 
respondents that listed “Riding instructor/coach/professional professional” as describing their 
involvement with horses 
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Table A.2: Associations between different demographic factors associated with influenza, tetanus, herpes 
and any vaccination. 
 
Variable association 
 Coefficient 
Standard 
error of 
coefficient 
Wald P 
value 
Log 
likelihood P 
value 
Odds 
ratio 
Odds ratio 
95% 
Confidence 
Intervals  
Own premises - Wales 0.83 0.14 <0.001 <0.001 2.29 1.73-3.02 
Own Premises - South West England 0.40 0.09 <0.001 <0.001 1.50 1.26-1.78 
Breeder - Wales 0.77 0.21 <0.001 <0.001 2.16 1.42-3.27 
Breeder - Non rider 1.24 0.17 <0.001 <0.001 3.46 2.48-4.85 
Breeder - Own premises 1.04 0.12 <0.001 <0.001 2.82 2.21-3.6 
Breeder - Extra horses owned 0.14 0.01 <0.001 <0.001 1.15 1.13-1.18 
>34 years old - Own premises 0.73 0.12 <0.001 <0.001 2.08 1.64-2.66 
>34 years old - Breeder 0.67 0.23 0.004 <0.001 1.96 1.24-3.09 
>34 years old - Extra horses 0.06 0.02 <0.001 <0.001 1.06 1.03-1.1 
>34 years old - Non rider 1.07 0.30 <0.001 <0.001 2.91 1.61-5.25 
Professional - International travel 1.37 0.22 <0.001 <0.001 3.93 2.57-6 
Male - Owner non rider 0.58 0.25 0.019 0.03 1.79 1.19-2.91 
<16 years old - Loans/rides non owner 1.27 0.53 0.018 0.02 3.55 1.25-10.12 
Male - Extra horses 0.03 0.01 <0.001 <0.001 1.03 1.01-1.04 
Male  - Non rider 0.58 0.25 0.019 0.03 1.79 1.1-2.91 
Scotland - Livestock farm 0.49 0.14 <0.001 <0.001 1.64 1.25-2.15 
South West England - livestock farm 0.45 0.12 <0.001 <0.001 1.56 1.24-1.97 
Driving - Pasture only 0.69 0.18 <0.001 <0.001 1.98 1.39-2.83 
Driving - Extra horses 0.03 0.01 <0.001 <0.001 1.03 1.01-1.04 
Driving - Breeding 0.67 0.19 0.001 <0.001 1.95 1.34-2.86 
Travel to activities - International travel 1.81 0.59 0.002 0.00 6.11 1.94-19.32 
Professional - travel to activities 0.75 0.23 0.001 <0.001 2.11 1.34-3.33 
Professional - International travel 1.37 0.22 <0.001 <0.001 3.93 2.57-6 
Professional - Affilliated events  0.94 0.12 <0.001 <0.001 2.56 2.02-3.23 
Professional- Nonaffilliaated events 0.76 0.13 <0.001 <0.001 2.14 1.65-2.77 
Professional-Hunting 0.81 0.12 <0.001 <0.001 2.25 1.77-2.87 
Professional -Breeding 0.86 0.13 <0.001 <0.001 2.37 1.83-3.06 
Professional - Dressage 1.19 0.14 <0.001 <0.001 3.29 2.51-4.3 
Professional - Trailblazers 0.65 0.16 <0.001 <0.001 1.92 1.41-2.61 
Professional - Show-jumping 0.85 0.12 <0.001 <0.001 2.34 1.84-2.96 
Professional - Eventing 0.85 0.12 <0.001 <0.001 2.33 1.83-2.97 
Professional - Showing 0.33 0.12 0.006 0.01 1.39 1.1-1.75 
Professional - Vaulting 1.21 0.34 0.000 <0.001 3.35 1.73-6.48 
Professional - Point-to-point 0.70 0.27 0.010 0.02 2.02 1.18-3.44 
Professional - Riding/pony club 0.57 0.12 <0.001 <0.001 1.76 1.4-2.22 
Professional - Lessons 0.87 0.15 <0.001 <0.001 2.39 1.79-3.19 
Professional - Facilities at a different premises 0.87 0.15 <0.001 <0.001 2.39 1.79-3.19 
Professional - Lessons at a different premises 0.80 0.13 <0.001 <0.001 2.22 1.72-2.87 
Affilliated activities - private yard 0.19 0.09 0.036 1.2 1.01-
1.43 
1.43 
Affilliated - road hours to activities 0.017 0.004 <0.001 1.02 1.01-
1.03 
1.03 
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Appendix for Project 3: 
 
Figure A.4: The pilot study of Dr. Mark McLaughlin found significantly reduced levels of 
phosphotydlinositol 4,5 bisphosphate in the myelin of C3H rumpshaker mice compared to that of C3H 
wild-type mice. (n=4, studnets’s T test P value = 0.0005). 
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Figure A.5: Western blot analysis showing proteolipid protein (PLP) in C3H wild-type (W) and 
rumpshaker (R) pellet and myelin fractions. Quantitative analysis indicates significantly less plp in the 
nyelin of the rumpshaker. (P=0.043) Limited inference can be made from this result due to poor quality of 
the western blot. 
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Figure A.6: Western blot analysis of phosphorylated MBP (PhMBP) in wild-type (W) and rumpshaker (R) 
myelin. The signal intensity was not measured due to hetrogenous blot quality. 
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